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Abstract 
Sensory neurons are a heterogeneous group of cells that are specialized to detect stimuli 
acting on the skin such as touch, temperature, pain and itch. A major challenge in the sensory 
biology field is to isolate and characterize specific functional subsets of neurons as an 
exhaustive knowledge of many of them is still lacking. 
In my PhD project I established a protocol to analyse and sort by Fluorescently Activated Cell 
Sorting (FACS) peripheral sensory neurons, in order to isolate specific subsets and further 
perform gene expression profiling. 
In particular I applied these techniques to Avil-Cre::ReteGFP mice, where Ret-positive neurons 
express eGFP specifically in Dorsal Root Ganglia (DRG) neurons after Cre recombination. 
Ret is a receptor for the GDNF family expressed in at least 3 sensory neuron subsets: non-
peptidergic nociceptors, Rapidly Adapting (RA) mechanoreceptors and C-fiber low-threshold 
mechanoreceptors. However, our immunohistochemical analysis suggested that there might 
be more Ret-positive subsets. 
I analysed Ret-positive neurons by FACS, combining the analysis of the pattern of 
endogenous eGFP expression with IB4-binding arrangement and I identified 5 diverse Ret-
eGFP-positive subsets. I focused on two of them, Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg 
that did not bind to IB4 and expressed low and high levels of eGFP, respectively. Their 
expression profiles suggested that Ret-eGFPHi:IB4Neg neurons represent the previously 
described RA Mechanoreceptors, while the Ret-eGFPLo:IB4Neg subset constitutes a new Ret-
positive class of sensory neurons involved in itch perception.  
To verify this assumption, we functionally characterized Ret-eGFPLo:IB4Neg neurons. We 
focused on three molecules whose receptors we found enriched in the subset: histamine, a 
well known pruritogen, IL-31, a cytokine that has been linked to the pathology of Atopic 
Dermatitis, and LY344864, a serotonin agonist whose receptors, 5-HT1f, was among the most 
expressed genes within the Ret-eGFPLo:IB4Neg subset. By calcium imaging we demonstrated 
that these substances are able to elicit a neuronal response mainly in Ret-eGFP/IB4 negative 
cells. Moreover, when injected in the nape of the neck of mice, they all cause scratching, 
substantiating a putative role of this population as itch receptors.. 
My data indicate that we have discovered a new Ret-positive subset of sensory neurons 
involved in itch perception. A more extensive characterization of these cells, for example with 
a Sst-ires-Cre line which we found to specifically mark Ret-eGFPLo:IB4Neg subset, will 
further clarify their role within the DRG in vivo. 
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1. Introduction 
 
1.1.The somatosensory system: a historic overview 
 
In our everyday life we experience a myriad of somatic sensations that can be as different as a 
caress and a painful slap or a cold wind and a steaming sauna. 
Somatic sensibility allows us to perceive stimuli originating from the external world, so 
permitting our interaction with it and also fulfilling a very important protective role as, for 
example, feeling the heat of a boiling pan can prevent our hand from burning and perceiving 
the tickle caused by an insect can avoid dangerous stings. Moreover, the somatosensory 
system has an interoceptive and a proprioceptive function for the sensing of stimuli coming 
form inside of the body and the perception and balance of our limbs and trunk, respectively. 
Conventionally, there are four major sensory modalities: touch, pain, warm and cool. 
This classification comes from studies in the 1880s in which was shown, independently by 
Blix, Goldscheider and Donaldson, that specific skin spots for touch, warm and cold exist 
(reviewed in Norrsell et al, 1999). Whether pain could be considered a specific sensation has 
been for a long time on a debate. Max von Frey, in 1896, was able to provoke pain without 
evoking touch sensation by employing thin and sharp plant spicules. He proposed the 
“specificity theory” in which he claimed that pain is a distinct sensation. However 
Goldscheider came to different conclusion by using the same kind of stimulators but inserting 
the spicules slantwise. He formulated an ”intensity hypothesis” of pain: a stimulus of weak 
intensity always evokes touch-like sensations and only when it becomes more intense the 
sensation can turn into pain (Goldscheider, 1898).  
During the last years a similar debate has been ongoing about the existence of itch as a 
separate sensation. Although itch is now mostly listed among the sensory modalities, many 
aspects about its physiology and its relation to pain are still enigmatic, as it will be discussed 
in the next chapter. 
All the findings in the late 1880’s supported the idea that specific neural circuits convey the 
information from the skin to the brain, as proposed by Mueller in 1837 in his “law of specific 
nerve energies” in which he states that morphologically distinct receptors convey information 
to the brain through nerve fibers specific for that modality (Mueller, 1837). 
However, nowadays we know the situation to be much more complex. For example, the same 
perception could be evoked by different stimuli or a similar stimulus can be perceived 
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differently in a normal versus pathological condition (Ma, 2012). Most likely the specific 
labeled lines do exist, but they also crosstalk among each other, as several recent studies have 
shown (Lagerstrom et al, 2010; McCoy et al, 2013; Roberson et al, 2013). 
 
1.2. Peripheral sensory neurons 
The components of the above-mentioned “lines” that detect the external and internal stimuli 
are the primary sensory neurons whose cell bodies lie in the Trigeminal Ganglia (TG) and in 
the Dorsal Root Ganglia (DRG), innervating the cranial structures and the limbs and trunk, 
respectively.  
Primary sensory neurons have a unique morphology: they are pseudounipolar, that is their 
central and peripheral teminals originate from a common axis and, unlike the other types of 
neurons, are not biochemically distinct. Although the peripheral afferent is the only one that 
can perceive the stimulus, axon and dendrite of the same neuron share the majority of proteins 
synthetized by the cell and can be both targeted by endogenous molecules that regulate 
neuronal sensitivity (Basbaum et al, 2009). 
The peripheral branches reach the skin or the internal organs where the sensory signal is 
transduced into an electrical signal, involving the opening of ion channels in the membrane 
following a mechanical deformation, a change in the temperature or the contact with 
molecules released from damaged tissue. The central afferents end up in the dorsal horn of the 
spinal cord, which is organized into anatomically and electrophysiologically distinct laminae. 
This neuronal structure it is suitable to their role in stimulus transduction and its transmission 
to the central nervous system. 
Primary sensory neurons detecting different stimuli can be quite diverse in their morphology, 
electrophysiological characteristics and molecular signature. They can be classified as Aβ, Aδ 
or C type depending on their cell body size, their axonal diameter and its level of myelination 
and conduction velocity. Aβ sensory neurons have large cell bodies and heavily myelinated 
afferents, thereby displaying very rapid conduction properties, the velocity varying from 16 to 
100 m/s.  
Aδ subtype exhibits medium size cell bodies and lightly myelinated fibers, which lead to 
intermediate conduction velocities, ranging from 5 to 30 m/s. The smallest and the most 
abundant sensory neurons are the C-type, They have unmyelinated processes and the lowest 
conduction velocities, from 0,2 to 2 m/s. 
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Sensory neurons also differ in their firing patterns, as distinct subtypes fire with different 
velocities and for a variable time. In fact the thresholds of activation and the duration of the 
sensation can be variable as distinct receptors can adapt slowly or rapidly to sustained stimuli. 
It is clear that all the characteristics mentioned above exist because of a differential 
expression of genes within different sensory neuron subpopulations. Many of these molecules, 
however, are still unknown, and this lack of information makes our understanding of the 
physiology of the peripheral nervous system still puzzling. 
Nevertheless, we can broadly distinguish some classes of primary sensory neurons according 
to their function. 
The sensory neurons that detect discriminative, innocuous touch are called mechanoreceptors. 
They all have low thresholds of activation (LTMR- low threshold mechanoreceptors), being 
activated by weak, innocuous mechanical force applied to the skin. Their firing patterns, on 
the other hand, can be quite different as they can range from slow (SA) to intermediate (IA) 
and to rapidly adapting (RA). 
Even though most of them are Aβ neurons, a subset of neurons sensitive to down hair 
movement, known as D-hair, have Aδ fibers and recently several subsets of C-type LTMR 
have been described ((Li et al, 2011; Vrontou et al, 2013). 
Mechanoreceptors can be further distinguished based on the cutaneous end organs with which 
they associate, which is also directly linked to the type of stimulus they are tuned by. 
Mammalian skin can be distinguished into 2 types, glabrous and hairy. There are 4 major end 
organs present in the glabrous skin: Merkel cells, which respond to indentation (and are also 
present in hairy skin), Meissner corpuscles which are associated to fibers that detect skin 
movement, Pacinian corpuscles that fire upon vibration and Ruffini organs, involved in 
stretch perception.  
In hairy skin, LTMR are associated with hair follicles, which are specialized mechanosensory 
organs. There are 3 hair types that differ in abundance, length and pattern of LTMR subtype: 
zigzag, awl/auchene and guard hair. The zigzag type is the most abundant (76%) and receives 
C and Aδ-LTMR lanceolate endings, Awl/auchene hair follicles (23%) are innervated by 
endings of Aβ-RA-LTMR, Aδ-LTMR and C-LTMR, while the guard hair, which represent 
only 1% of hair follicles, are innervated by Aβ-RA-LTMR and are associated with Aβ-SA-
LTMR (Li et al, 2011).. 
Centrally, the mechanosensory afferents innervate the deeper laminae of the dorsal horn of the 
spinal cord, namely from lamina III to V. 
	   5	  
From a molecular point of view, mechanoreceptors are associated by the expression of the 
gene Nefh, which encodes for the heavy protein neurofilament subunit (NF200) and which is 
largely used as a marker for this class of sensory neurons. It is also known that Rapidly 
Adapting mechanoreceptors express the tyrosine kinase receptor Ret (Bourane et al, 2009; 
Luo et al, 2009), but a complete molecular signature of the different functional subsets of 
mechanoreceptors, as well as of other sensory neuron subtypes, is still missing.  
Regarding their physiology, for many years scientists have been seeking for a channel 
responsible for mechanical sensitivity transduction. Recently a good candidate has been 
identified: it is called Piezo 2 (Coste et al, 2012). However, its role as mechanotransducer is 
still under examination and it is likely that other channels could also be involved in the 
physiology of touch sensation.  
Intense thermal, mechanical or chemical stimuli are detected by nociceptors, the primary 
sensory neurons involved in pain perception. They usually have high threshold of activation 
and Aδ or C fibers which all end in the skin as free nerve endings. It is possible to distinguish 
2 classes of nociceptors according to the expression of neuropeptides. The so-called 
“peptidergic” nociceptors express neuropeptides such as substance P and CGRP (calcitonin-
gene related protein) and innervate the deeper region of the skin, the dermis. They also 
express the neurotrophic receptor TrkA. 
The “non-peptidergic” nociceptors are characterized by their ability to bind to isolectin B4 
(IB4) and by expression of the neurotrophic receptor c-Ret. Their peripheral afferents reach a 
more superficial part of the skin, the epidermis. 
These classes of nociceptors also reach different dorsal horn laminae: the peptidergic subtype 
innervates the most superficial lamina 1, while the non-peptidergic nociceptors reach the outer 
part of lamina II.  
Nociceptors are usually polymodal, that is, they are able to respond to more than one 
stimulus. For example, there is a subset of Aδ nociceptors that can be activated by mechanical 
and chemical stimuli and can further respond to heat with a high threshold of activation. If the 
heat stimulus is maintained they will start responding to lower temperature and also become 
more sensitive in case of tissue injury. Another class of Aδ nociceptors, on the contrary, have 
lower heat thresholds and a much higher mechanical thresholds (Basbaum et al, 2009) 
The different response of nociceptors to painful stimuli depends on a differential expression 
of channels that confer sensitivity to heat, cold, and chemical irritants. Transient receptor 
potential (TRP) ion channel family has a major role in pain perception: TRPV1 channel, for 
example, the receptor for the red hot chili pepper ingredient capsaicin, is the main endogenous 
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transducer for noxious heat (Caterina et al, 1997), while TRPM8, the menthol receptor, is the 
principal detector of enviromental cold (Bautista et al, 2007). Chemical irritants activate the 
TRPA1 channel, which may also be involved in cold perception (Bandell et al, 2004; Peier et 
al, 2002). 
 
1.3. Itch 
 
1.3.1. General aspects and the link with pain 
 
Itch, or pruritus, is an “unpleasant sensation that elicits the desire or reflex to scratch”, as 
defined by the German physician Samuel Haffenreffer 350 years ago. (Lavinka & Dong, 
2013). The scratching provoked by pruritus has a protective role, as it results in the physical 
removal of a potentially harmful stimulus, and also helps suppressing the irritating itchy 
sensation by causing mechanical pain, which has been reported to inhibit itch in both humans 
and mice (Akiyama et al, 2011; Yosipovitch et al, 2007). 
However, itch can be also associated to pathological conditions and become chronic, so 
seriously affecting upon the quality of life. Chronic itch is a complex sensory experience with 
sensory discriminative, cognitive, evaluative and motivational components (Ikoma et al, 
2006), although the pathophysiology of most clinical itch conditions is unknown.  
Chronic itch can arise for several reasons: it can be caused by skin diseases such as psoriasis, 
atopic dermatitis, urticaria, etc  (pruriceptive itch), it can be centrally induced due to systemic 
disorders such as chronic liver disease, chronic renal failure and thyroid disfunction 
(neurogenic itch) or to neurological disorders of the central or peripheral nervous system like 
brain tumor, nerve compression, etc (neuropathic itch) or it can even be related to 
psychological and psychiatric disorders such as parasitophobia and obsessive-compulsive 
disorder (psychogenic itch) (Biro et al, 2007).  
For a long time itch an pain have been considered as mediated by the same neurons: 
according to the “intensity theory” of itch proposed by von Frey in 1922, itch was caused by a 
weak activation of nociceptors, whereas a stronger stimulation was supposed to be responsible 
for the painful sensation (Biro et al, 2007).  
According to that theory, application of low concentration of algogens on the skin should 
cause itch instead of pain and varying the stimulation frequency should lead to a transition 
from one sensory modality to the other one. However, none of these characteristics has been 
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observed as varying the concentration of the applied algogen just causes pain of different 
intensity and a different frequency of stimulation produces more intense itch or pain but never 
a transition from the former to the latter (Stander & Schmelz, 2006).  
Recently it has become evident that a pruriceptive system exists, that is, there are primary 
sensory neurons that respond specifically and exclusively to pruritogenic stimuli as well as 
dedicated central itch processing. For example, it is well assessed that opioids produce 
analgesia but induce itch, probably by acting on distinct dorsal horn neurons (Ballantyne et al, 
1988; Liu et al, 2011). Moreover, when ablating spinal cord lamina I neurons expressing the 
gastrin-releasing peptide receptor, mice showed a decrease in scratching response while no 
change in pain behaviour was observed (Sun et al, 2009). When central signalling of 
nociceptors is affected, mice show deficits in pain behaviours but also greatly enhanced 
itching (Liu et al, 2010b).  
Despite the evidence that pain and itch are mediated through different primary afferent 
pathways, the link between the 2 sensations is unquestionable. Pruriceptors and nociceptors, 
in fact, share mediators and mechanisms and are very similar in terms of both morphology 
and processing.  
In fact, pruriceptors express TRP channels, such as TRPV1 and TRPA1, that have a dual role 
in itch and pain and confer them the ability to respond also to stimuli that normally generate 
pain. Several theories have been proposed about how different stimuli can generate distinct 
itch or pain behaviours by activating the same channel. One is based on population coding: if 
a stimulus is purely pruritogenic will activate only itch-sensitive neurons, but if a stimulus 
activates both pruriceptors and nociceptors and it is strong enough to suppress itch at spinal 
level, a pain sensation will emerge. If the amount of pain is not sufficient to mask itch, then 
both itch and pain will be perceived. The “spatial contrast theory”, in alternative, states that 
the sensation that is evoked depends on the amount of activated neurons: if a small number is 
responding to a stimulus, itch sensation will be triggered, if more fibers are activated, then 
pain will be initiated.  
Despite the fact that during the last years many researches are focusing on the role of itch in 
somatosensation, its relationship with pain is still under debate and many aspects of its 
physiology are still unkown. 
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1.3.2. Pruriceptors 
 
Itch sensation can be distinguished into submodalities, which are likely to be perceived by 
different subsets of pruriceptors. Some of these subsets have been identified but several 
aspects of the pruriceptive system remain unclear.  
Sensory neurons mediating itch sensation, likewise nociceptors, can have either Aδ and C 
fibers and it is considered that the former encode for the pricking/stinging sensation (Graham 
et al, 1951; Ringkamp et al, 2011) and the latter for the burning perception.  
At least 2 Aδ subsets have been described in human and non-human primates: one is 
mechanosensitive and activated by the pruritogen cowhage (Mucuna pruriens), and the other 
one is mechanoinsensitive and responsive to histamine (Ringkamp et al, 2011). 
However, the majority of itch receptors have unmyelinated afferents in both human and mice. 
It is possible to further classify them according to the type of pruritogen they are activated by. 
In fact, not all the pruriceptors respond equally to the various stimuli that cause itch: for 
example, a subset of mechano- and heat-responsive C fibers respond to cowhage and 
histamine (Ma et al, 2012) while there are some mechanoinsensitive C-type neurons that 
respond to histamine but not cowhage (Namer et al, 2008).  
 
Figure 1. Pruriceptors innervate the skin where they can be activated by endogenous and 
exogenous itch-inducing substances, in a process that involves also immune system cells and 
keratinocytes. There are different subsets of pruriceptors that are activated by different 
pruritogens and whose activation follows different pathways. Taken from a recent review on 
itch receptors (Bautista et al, 2014) 
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1.3.3. Itch mediators and receptors 
 
There are a variety of substances that can cause pruritus through activation of different 
receptors expressed by primary sensory neurons. 
Histamine is naturally produced by mast cells when tissues are inflamed or stimulated by 
allergens, and it is also the main pruriceptive agent used to experimentally induce itch in both 
human and non-human primates and mice. 
There are 4 subtypes of histamine receptors, named H1-H4, which are G-protein coupled 
receptors (GPCR). Only H1 and H4 have a role in itch sensation as shown by the observation 
that agonists specific for those subtypes evoke itch in mice, while antagonists suppress it 
(Davies & Greaves, 1980; Dunford et al, 2007).  
Histamine signal transduction in primary sensory neurons has been shown to be mediated by 
TRPV1 (Imamachi et al, 2009), a member of TRP family channels. Many of those channels 
play a role in numerous sensory transduction pathways, such as thermosensation, 
mechanosensation, taste, etc.  
TRPV1 is a heat- and ligand-activated cation channel, first identified as a receptor for the 
active ingredient of red hot chili peppers, capsaicin. Activation by heat and a variety of 
endogenous ligands leads to the influx of cations in the nerve terminal, depolarization and 
action potential propagation. 
However, histamine cannot account for all the types of itch perceived. Anti-histamine 
treatments are indeed ineffective in some chronic itch diseases such as atopic dermatitis 
(Yosipovitch & Papoiu, 2008).  
There is emerging information about compounds that drive itch sensation without the 
involvement of histamine and a growing evidence suggests an important role of another TRP 
channel family member, TRPA1, in these histamine-independent pathways. TRPA1 can be 
activated by a myriad of irritants, both endogenous and exogenous, and acts as a general 
mediator of inflammation. The most well known exogenous substance that activates TRPA1 
is allyl isothiocyanate (AITC, or mustard oil), the pungent compound found in wasabi or 
mustard, but also cinnameldehyde (from cinnamon) and allicin (fron garlic extracts) can target 
the channel. Moreover, several endogenous inflammatory agents and reactive oxygen species 
can directly activate TRPA1. 
Its role in itch emerged when the members of the Mas-related G-protein coupled receptor 
family, MrgprA3 and MrgprC11, were studied. These receptors are activated by Chloroquine 
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(CQ) and BAM8-22, respectively, which evoke calcium signals in a histamine-independent 
pathway, through activation of TRPA1(Wilson et al, 2011).  
While it is evident that histamine-dependent and histamine-independent itch signal through 2 
different molecular mechanisms (TRPV1 and TRPA1 channels, respectively), it is still under 
debate whether this activation can occur within the same neuronal subsets (Han et al, 2013) or 
whether each pathway of activation has also a dedicated subgroup of primary sensory neurons 
(Roberson et al, 2013). 
Another endogenous substance that can cause pruritus is serotonin. 
Reaction to serotonin differs between rodents and human. In rodents, mast cells are the 
primary source of serotonin while in humans that is not the case, even though human mast 
cells can synthetize and secrete it. Moreover, rats and mice scratch when the molecule is 
injected in their faces or backs (Akiyama et al, 2009; Klein et al, 2011), while in humans 
serotonin injections cause only weak itch or mixed feeling of itch and pain, through activation 
of a subset of cutaneous c fibers (Schmelz et al, 2003). The pruritus caused by serotonin is not 
suppressed by anti-histamines, thus suggesting a histamine-independent pathway (Hosogi et 
al, 2006). In mice, serotonin acts on several receptors but to date only the 5-HT2 receptor 
subtype has been shown to be involved in itch-sensation (Yamaguchi et al, 1999). 
Upon activation, pruriceptors release substance P (SP), which can indirectly cause itch by 
stimulating mast cells to produce and release histamine and other pruritogens.  
Application of SP on human skin does cause pruritus that is prevented by subministration of 
antihistamines, pointing towards a histamine-dependent pathway (Hosogi et al, 2006). 
Interestingly, although SP induces scratching behaviour in mice, antagonists of histamine 
receptors does not prevent pruritus (Andoh & Kuraishi, 1998).  
SP preferentially activates neurokinin 1 (NK1) receptors. Their antagonist, indeed, attenuated 
itch severity in both human and mouse model of chronic itch (Ohmura et al, 2004; Stander et 
al, 2010). 
Endogenous serine proteases secreted by mast cells, such as tyrosine, kallikreins or tryptase, 
and exogenous ones released by a plant that has been extensively used in the sensory neuron 
field, Mucuna pruriens (or Cowhage) induce itch in both humans and mice through activation 
of a GPCR family, the Protease Activated Receptor (PAR) family. There are four PARs, three 
out of which have been shown to cause scratching in mice: Cowhage activates PAR2 and 
PAR4 which act through an histamine-independent pathway (Reddy et al, 2008), even though 
histamine-independence of PAR4 is somewhat controversial (Tsujii et al, 2008). Exogenous 
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proteases such as the active component of cowhage and the PAR agonist SLIGRL are also 
able to induce itch and are in fact widely used to assess scratching behaviour in mice. 
Increased tryptase serum levels and PAR2 expression in keratinocytes and nerve fibers have 
been described in patients with atopic dermatitis (Steinhoff et al, 2003). 
Itch can be also driven by cytokines.  
Cytokines can communicate with sensory neurons indirectly, by activating immune and 
resident skin cells and thus provoking a release of mediators that can bind to sensory fibers, 
but also directly, by activation of specific receptors on the neuronal surface.(Saika et al, 2012) 
Some members of the inflammatory immune-cell derived interleukins are involved in the 
pathogenesis of itch. In particular such a role has been shown for IL-2 (Martin & Murphy, 
1995), IL-4 (Chan et al, 2001) and in particular for one of the components of the IL-6 family 
of cytokines, namely IL-31 (Dillon, Sprecher et al. 2004; Sonkoly, Muller et al. 2006),  
An involvement of IL-31 in the pathogenesis of atopic dermatitis has been found in both 
human and mice (Dillon et al, 2004; Sonkoly et al, 2006).  
IL-31 is produced by T helper type 2 cells and acts on heterodimeric receptors consisting of 
Interleukin 31 receptor α and Oncostatin receptor M β (Zhang et al, 2008). These receptors 
have been localized in a small subset of murine TRPV1+/TRPA1+ dorsal root ganglia 
neurons, and a direct action of IL-31 on nerve fibers has been recently described (Cevikbas et 
al, 2013). 
Another cytokine with a role in atopic dermatitis has been recently discovered: it is an 
epithelial cell-derived cytokine called thymic stromal lymphopoietin (TSLP). It probably acts 
on both primary sensory neurons and immune cells to evoke itch behaviours. The neuronal 
targets express the ion channel TRPA1, suggesting a histamine-independent pathway for 
triggering itch. 
Recently, much attention has been focused on a new family of receptors, Mrgpr (Mas-related 
G-protein coupled receptor family). 
The Mrgpr family of receptors was discovered in 2001 (Dong et al, 2001). Their expression 
pattern suggests a specific role in somatosensation as many members are exclusively 
expressed in dorsal root ganglia. 
In mice, the receptors can be grouped into 3 subfamilies: MrgprA, MrgprB and MrgprC, for a 
total of 50 genes and pseudogenes. In humans there are only 18 members and their similarity 
to mouse sequences is fairly low. 
A role in itch has been assessed for MrgprA3 and MrgprC11. The former is the receptor for 
Chloroquine (CQ) an antimalarial drug that has as a side effect a strong pruritus, the latter is 
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activated by a Bovine Adrenal Medulla peptide (BAM8-22). They both activate histamine-
independent pathways of itch sensation and require TRPA1 for the insurgence of action 
potential (Wilson et al, 2011). However their pathways are different as MrgprA3 signalling 
requires an active Gbeta/gamma complex while MrgprC11 requires phospholipase C as an 
intermediate (Wilson et al, 2011).  
Interestingly, MrgprA3 and MrgprC11 largely overlap in DRG neurons (Zylka et al, 2003). 
Moreover, TRPV1 is present in this subset, but is not required for signalling (Wilson et al, 
2011) and these neurons are also activated by histamine (Liu et al, 2009), pointing towards a 
possible presence within the same cells of histamine-dependent and histamine-independent 
pathways. 
Other receptors that have been involved in the detection of pruritus are the Toll-like receptors. 
They have an important role in controlling innate immunity (Akira et al, 2006), but they are 
also expressed in neurons in both central and peripheral nervous system (Liu et al, 2012b; 
Okun et al, 2011), being in the latter involved in acute and chronic itch (Liu et al, 2012b; Liu 
et al, 2010a). 
Such a role has been assessed for TLR3 and TLR7, which are expressed in subsets of small-
sized, TRPV1-positive sensory neurons and they are considered to drive itch sensation 
associated with skin infection and tissue injury. These neurons also express GRP, a 
neuropeptide that elicits itch (Sun & Chen, 2007). 
TLR7 recognizes some drugs such as imidazoquinoline derivatives and guanine analogs. Its 
ablation leads to reduction of scratching behaviour in response to non-histaminergic 
pruritogens while leaves unaltered the responses to histaminergic substances (Liu et al, 
2010a). TLR3 ablation affects both histamine-dependent and histamine-independent itch (Liu 
et al, 2012a).  
 
1.3.4. Spinal coding of itch 
 
Many recent studies have focused on the spinal trasmission of itch, leading to the discovery of 
several neurotransmitters responsible for it, in particular the Gastrin-releasing peptide (GRP), 
Substance P (SP) and glutamate.  
SP and GRP have been involved in itch sensation because neurotoxic ablation of their 
receptors in the dorsal horn of the spinal cord, Neurokinin-1 receptor and GRP-receptor, 
respectively, reduced scratching behaviour in response to Chloroquine. They did not, 
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however, affect histamine response, suggesting a role of these neurons in histamine-
independent itch (Akiyama et al, 2013). Notably, the ablation didn’t affect pain behaviour. 
Regarding glutamate, it might be involved in the sensing of histamine-dependent itch as 
antagonists acting on its spinal receptor AMPA/kinate abolished neuronal activity of 
histamine-responsive spinal neurons (Koga et al, 2011). 
Another molecule that has been found to have an important role in spinal itch transmission is 
the Natriuretic Polypeptide B (nppb) (Mishra & Hoon, 2013). Nppb is expressed in a subset of 
small unmyelinated, TRPV1-, MrgprA3- and PLCβ-positive sensory neurons, and its receptor 
Npra is found in Lamina I spinal neurons. Nppb knockout mice exhibit reduced scratching 
behaviour in response to many pruritogenic compounds but pain responses were not altered 
(Mishra & Hoon, 2013).  
Following their observations and the report that most of the GRP is espressed by spinal rather 
than sensory neurons (Fleming et al, 2012), Mishra and Hoon (Mishra & Hoon, 2013) propose 
a theory in which nppb is released by pruriceptors and excites Npra-positive neurons in the 
spinal cord, which in turn activate GRPR-positive downstream spinal neurons that are then 
responsible for the transmission of itch to the higher centres.  
It has also been shown that itch can be inhibited by different types of pain (thermal, 
mechanical, chemical or electrical) at spinal level. The normal reaction to itch itself, which is 
scratching, inhibits the pruriceptor firing (Akiyama et al, 2012) .  
It is believed that there are interneurons in the spinal cord that release inhibitory 
neurotransmitters such as glycine and GABA that mediates the above mentioned pruriceptive 
inhibition (Akiyama et al, 2011). 
Ablation of the transcription factor Bhlhb5 causes a selective loss of a subset of inhibitory 
neurons in the spinal cord that results in enhanced scratching response to pruritic agents (Ross 
et al, 2010).  
Excessive scratching behaviour was also observed when knocking out the glutamate 
transporter VGLUT2 in a class of nociceptors (Lagerstrom et al, 2010; Liu et al, 2010b).  
These findings point toward the idea that inhibitory interneurons are tonically active and only 
when their activity is reduced or abolished the itch sensation is unmasked. 
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1.4. The tyrosine kinase RET 
 
1.4.1 Ret function and distribution: an overview 
 
The development of many primary sensory neurons depends on growth factors, such as nerve 
growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), 
neurotrophin 4 (NT4) and the glial cell-line derived neurotrophic factor (GDNF) family. 
Different subsets of sensory neurons usually express receptors specific for one or few 
neurotrophic factors, so that each of them exerts its function on a specific subpopulation.  
Around 60% of DRG neurons express Ret, the signalling receptor for the GDNF family 
(Molliver et al, 1997), which has four members: GDNF, Neurturin, artemin and persephin. 
RET was first described as a proto-oncogene and it has been implicated in the progression of 
several types of tumors. It is a single-pass transmembrane tyrosine kinase that is required for 
normal development, maturation and maintenance of several tissues and cell types and is a 
highly conserved protein, from Drosophila through human (Mulligan, 2014). Its important 
role within the organism it’s underlined by the fact that mutations associated with loss or 
reduction of RET function cause pathologies in humans and RET null mice die soon after 
birth (Schuchardt et al, 1994).  
It is mostly expressed during embryogenesis and it has been demonstrated to be important for 
the development of the kidney, for spermatogonial stem cell maintenance, and it has multiple 
functions in the neuroendocrine and nervous systems. It is expressed in neural crest cells and 
it has an essential role for migration, development and maintenance of neurons of the central 
and peripheral nervous system (Mulligan, 2014). 
In vertebrates, RET acts in concert with the glycosyl-phosphatidyl inositol-linked (GPI-
linked) co-receptors called Gfrα1-4 that determine the ligand specifity of the receptor 
complex. GDNF binds to Gfrα1, Neurturin to Gfrα2, Artemin to Gfrα3 and Persephin to 
Gfrα4s. 
The ligand binds first to its specific Gfrα receptor and then interacts with RET, recruiting it 
into cholesterol-rich membrane subdomains (lipid rafts) where the complex dimerizes and 
tyrosine phosphorylation and subsequent downstream pathways of the signalling occur. 
(Mulligan, 2014; Tansey et al, 2000). 
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Figure 2. Ret is a transmembrane tyrosine kinase protein. It is the receptor for a family of 
soluble neurotrophic factors, GDNF. Its ligand specificity is determined by its co-receptors: 
they are 4 and belong to the GDNF family receptor α (Gfrα) family members. Part of a 
picture taken from Mulligan, 2014 ((Mulligan, 2014) 
 
 
1.4.2. Ret in sensory neuron subsets 
 
To date, Ret expression has been detected and characterized in 3 different sensory neuron 
subpopulations. 
Of these, the most abundant and widely studied is the non-peptidergic nociceptor subtype. 
These neurons are born around embryonic day (E) 11,5 or later and at this stage they express 
TrkA, the receptor for the nerve growth factor (NGF). NGF controls Ret, Gfrα1 and Gfrα2 
expression and these neurons begin to express Ret around E15,5 and, from P0 onward, Gfrα1 
and Gfrα2. Ret signalling then autoregulates the expression of its co-receptors and determines 
the gradual extinction of TrkA expression, completely abolishing it around postnatal (P) day 
14 (Luo et al, 2007). Moreover, it regulates the expression of several ion channels that are 
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known to be enriched in the non-peptidergic nociceptor subset, namely TRPA1, MrgprA1, 
MrgprA3, MrgprB4. Ret signalling is not necessary for neuronal survival, but it is crucial for 
normal cell size and for peripheral target innervation (Luo et al, 2007). 
Among the Gfrα co-receptors, non-peptidergic nociceptors mainly express Gfrα2 (Luo et al, 
2007). 
There is a distinct, smaller population of Ret -positive neurons that are born prior to E11, 5 
and express Ret from the beginning. These neurons do not express TrkA in any of their 
developmental stages and have large soma size. This subset, which is also known as the 
Early-Ret subpopulation, was hypothesised to be constituted by low-threshold 
mechanoreceptors and thus involved in the perception of discriminative touch stimuli. This 
was also supported by the observations regarding their peripheral and central afferents that 
were found around the hair follicle and in the mechanosensitive area of the dorsal horn of the 
spinal cord, respectively (Molliver et al, 1997). 
The Early-Ret subpopulation was characterized more extensively in 2009 (Bourane et al, 
2009; Luo et al, 2009) when it was shown that these neurons are Rapidly Adapting Low-
threshold mechanoreceptors and therefore responsible for detecting vibration and pressure. 
The Ginty group (Luo et al, 2009) used a mouse line in which the early-Ret population was 
genetically labelled to examine in detail this subset. They demonstrated that early Ret positive 
neurons have a large soma size and that they project centrally to lamina III-V of the dorsal 
horn of the spinal cord and peripherally to Meissner corpuscles, longitudinal lanceolate 
endings and Pacinian corpuscles. They also showed that at P14 all the early-Ret neurons 
coexpress Gfrα2. Moreover, they used a conditional Ret KO mouse to demonstrate that Ret 
signalling is not necessary for the survival of RA mechanoreceptors but is crucial for the 
development of Pacinian corpuscles and for proper central innervation. 
Almost identical conclusions were made by Carroll group (Bourane et al, 2009). 
By using immunohistochemistry and a RETcKO mouse, they also identified early-Ret 
neurons as RA mechanoreceptors and showed the importance of Ret in proper development 
and innervation of this subset. They further found an additional marker for this subset which 
is expressed during the embryonic stage, the transcription factor MafA. 
A third population of Ret-positive sensory neurons has been recently identified (Li et al, 
2011): they are small-diameter DRG neurons which do not express any other marker for non-
peptidergic nor for peptidergic nociceptors. These neurons are characterized by the expression 
of TH (tyrosine hydroxylase).  
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By using an ex vivo skin nerve preparation, the authors observed that this subset was 
composed of fibers that displayed the classical features of C-fiber Low-Threshold 
mechanoreceptors. Moreover, more than 80% of TH-positive neurons expressed vGlut3 
mRNA, which is found in C-LTMRs (Seal et al, 2009).  
The authors genetically labelled TH-positive neurons and observed that their peripheral 
projections form longitudinal lanceolate endings that associate with 2 types of hair 
follicles(Driskell et al, 2009): the zig-zag (80% of C-LTMR) and awl/auchene (20% of C-
LTMR) hair. 
C-LTMRs have dual functions: under normal condition they detect the affective or emotional 
component of touch, but in pathological conditions they can cause pain and contribute to 
touch hypersensitivity after injury. Recently, it has been observed that the threshold of 
activation of these neurons is modulated by TAFA4, a chemokine-like secreted protein 
(Delfini et al, 2013). 
Thus Ret marks several sensory neuron subpopulations and has an important physiological 
role in the peripheral sensory system. Many recent studies have contributed to elucidate its 
expression pattern and function, but some of these also pose new questions, especially 
regarding its distribution within sensory neurons: it is likely, in fact, that Ret marks also other 
neuronal subsets than the ones described above.  
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2. Aim of the project 
 
The peripheral nervous system is formed by sensory neurons that differ appreciably in terms 
of function, morphology and electrophysiological properties. Identification and 
characterization of defined functional subsets is one of the main challenges of the field, and 
yet a lot about that is still unknown.  
Peripheral sensory neuron cell bodies cluster together in the Dorsal Root Ganglia without any 
defined arrangement, or at least any known to date, so functional subsets cannot be identified 
according to their position. Moreover, although several markers have been described, they 
often display an overlapping pattern and are rarely confined exclusively to only one 
subpopulation.  
In addition, many sensory neurons are polymodal, that is, they can detect different type of 
stimuli or, for example, change their threshold of activation in presence of injury thus 
modifying their response.  
Identification of discrete subpopulation of DRG neurons is therefore complicated and the 
tools that are commonly used to study them, such as immunohistochemistry, do not usually 
allow detection of very small subsets whose presence might be overwhelmed by the multitude 
of markers and their relative expression. 
We therefore sought to develop new tools for the analysis of sensory neuron subpopulations 
that allows not only identification and isolation of new subsets according to criteria such as 
expression of membrane markers and independently of their size, but a tool that also offers a 
pool of data for a complete characterization and proper investigation about systems biology of 
neuronal subsets. 
For that purpose we used fluorescence-activated cell sorting (FACS) techniques. FACS has 
never been used in the context of peripheral sensory neurons and we sought to develop a 
protocol for a successful isolation of specific subsets of such a delicate type of cells in order 
to be able to perform gene expression profiling on them. 
Information about expression of genes in a defined subset of sensory neurons has been 
obtained so far only by isolating neurons, for example, from mice lacking a specific gene and 
comparing the profile with the one obtained from total DRG of a wild-type mouse. In this way 
researchers have demonstrated how the expression is altered in absence of a particular gene 
and therefore its function, but the gene expression profile of a defined subset of sensory 
neuron has never been tested. 
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We focused on a group of neurons that specifically express eGFP protein using Ret gene as a 
driver. As mentioned above, Ret is present in at least 3 different neuronal subsets within the 
peripheral nervous system. Is it however likely that more Ret-positive populations exist as 
some studies have detected Ret expression in very small subsets of cells expressing markers 
different that the widely described IB4, NF200 or TH. For example, costaining with TrkA has 
been detected (Golden et al, 2010), as well as with TRPV1 and Gfrα3 (Elitt et al, 2006). 
The major aim of this proposal was therefore to further characterize and quantify by FACS 
the Ret-positive subsets, isolate them and perform microarray analysis in order to have a pool 
of potential markers, transducing molecules, transcription factors, etc that can widen our 
analysis and allow for a complete characterization of neuronal subsets. 
Based upon this strategy we identified at least five different subsets of Ret-positive neurons. 
We concentrated on the two of them who displayed the most homogeneous distribution and 
obtained their gene expression profiles.  
Our focus therefore became to understand the function of these populations. As a starting 
point we considered the type of transcripts that were specifically enriched in those subsets and 
we subsequently performed functional characterization. 
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3. Main results 
 
3.1. Immunofluorescent screening of Avil-Cre::ReteGFP/+ mouse sensory neurons 
 
In order to visualize all Ret-positive neurons in Dorsal Root Ganglia, we took a genetic 
approach. We crossed an Avilcre/+ mouse line, in which Cre is expressed exclusively in all 
peripheral sensory neurons (Zurborg et al, 2011), with a ReteGFP/+ line, where a “floxed” RET-
eGFP allele has been targeted into allele 1 of the mouse Ret locus and can be conditionally 
deleted in those cells that express Cre. eGFP expression occurs only when the allele is deleted 
(Jain et al, 2006). 
We obtained Avil-Cre::ReteGFP/+ mice which were viable, fertile and with no obvious 
abnormalities (> 1 year). With this strategy we specifically targeted Ret-positive DRG 
neurons avoiding any contamination from surrounding tissues, as Ret is widely expressed in 
nervous system. 
We first characterized Avil-Cre::ReteGFP/+ neurons by immunohistochemistry. We observed 
very strong endogenous eGFP fluorescence that was present in 55±5 percent of DRG neurons 
(n=3 mice, total of 4129 cells). Strikingly, we noticed a broad range of intensities among the 
Ret-positive cells. 
We costained DRG sections with markers that are known to mark specific ret-expressing 
sensory neuron subpopulations. We first used Isolectin B4 (IB4), which is a marker for non-
peptidergic nociceptors, and we found an overlap with eGFP-positive cells (Figure 3 A-H): 
more precisely, 51,5±3,8 percent of Ret-eGFP neurons bound to IB4, confirming that most of 
the Ret-positive neurons are indeed non-peptidergic nociceptors. Moreover, most of those 
neurons displayed small or medium size cell bodies and, as mentioned above (1.2.), this is a 
feature of nociceptive neurons. 
We also tested coexpression of Ret and NF200 in order to identify the early-Ret DRG neurons 
that constitute the RA mechanoreceptor group (Bourane et al, 2009; Luo et al, 2009), 
responsible for the detection of innocuous touch stimuli such as shape and texture. A small 
proportion of Ret-eGFP cells (13±1 percent) coexpressed NF200 (Figure 3 E-D, I-L). They 
also exhibited a large soma size, as typical for mechanoreceptors. 
The third Ret-positive subset, known to coexpress TH (tyrosine hydroxylase) (Franck et al, 
2011; Li et al, 2011), was also detected in our samples: 22±2,3 percent of Ret-eGFP neurons 
was positive for TH (Figure 3 E-L). 
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Importantly, we observed that there were Ret-expressing neurons that did not stain to any of 
the above-mentioned markers, and their proportion was consistent and worth further 
investigation. 
 
 
 
 
 
 
 
Figure 3. In DRG sections Ret-eGFP expression overlaps with IB4, a marker for non-
peptidergic nociceptors (A-H), with the mechanoreceptive marker NF200 (A-D, I-L) and with 
TH, which marks C-fiber low threshold mechanoreceptors. Arrows in D, H and L indicate 
neurons that express only Ret-eGFP. Scale bars, 50 μm. 
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Expression of eGFP was detectable also at the central and peripheral endings, which allowed 
us to further describe Ret-positive subsets. In the spinal cord Ret-eGFP intensity was 
detectable from lamina I through lamina V, even though in different proportions (Figure 4). 
This is consistent with previous observations (Luo et al, 2009). The densest plexus of 
expression was found in correspondence with IB4 labelling (Figure 4 A-H) in outer lamina II 
(IIo), delineating the innervation of the nonpeptidergic nociceptors and consistent with the fact 
that these neurons represent the largest population among the Ret-positive subsets. From 
lamina III to V Ret-eGFP expression was sparser and overlapped with the NF200-positive 
mechanoreceptive area (Figure 4 I-L), corresponding to the early-Ret group of neurons. EGFP 
fluorescence was also present in the internal lamina II (IIi), overlapping with PKCγ-positive 
interneurons present in that area (Figure 4 E-L). It has been shown that C-LTMR fibers 
terminate in lamina IIi (Li et al, 2011), so it is likely that those neurons correspond to the TH-
positive subset of Ret-positive neurons. We also noticed a small overlap of eGFP-positive 
fibers with CGRP in lamina I (Figure 4 A-D). 
Regarding the peripheral afferents of Ret-eGFP neurons, their wide distribution again 
confirms the heterogeneity of Ret-positive subsets: in fact the fluorescence was broadly 
distributed in both dermis and epidermis as free nerve endings and hair-encircling fibers 
(Figure 5). 
During the last years much information about Ret-positive neuronal subtypes has been 
emerging. We confirmed that there are 3 different groups of Ret expressing cell (IB4-positive 
nonpeptidergic nociceptors, NF200-positive RA mechanoreceptors and TH-positive C-fiber 
low-threshold mechanoreceptor) by immuohistochemistry, but our analysis also pointed out to 
the existence of at least one additional population that did not co-stain with any of those 
markers. 
Even though the utility of immunohistochemical tools is unquestionable, there are only a 
small number of antibodies that can be used together within the same experiment and it is 
difficult to investigate multiple subsets at the same time. Moreover, many markers are 
unknown, as are the majority of the molecules with a functional role in the systems biology of 
sensory neuron: their discovery would ease the progress of the field. 
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Figure 4. The central terminals of Ret-eGFP expressing neurons are broadly distributed 
within the dorsal horn of the spinal cord, from lamina I through lamina V. Ret-eGFP fibers 
are particularly dense in lamina IIo, where they overlap with IB4-binding terminals: this 
group constitutes the non-peptidergic nociceptor subset. Ret-eGFP expression was also 
detected in lamina IIi overlapping with PKCγ-positive interneurons, thus representing TH-
positive subtype. Ret-eGFP-positive afferents were also present from lamina III to V, the 
mechanoreceptive area, where they overlapped with NF200. Scale bars, 100 μm 
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Figure 5. Double immunostaining of Ret-eGFP and the pan-neuronal marker PGP9.5 on 
Avil-Cre::ReteGFP/+ mouse hairy skin. Ret-eGFP peripheral afferents are widely distributed in 
the dermis and epidermis, as free nerve endings (A-C) and hair encircling fibers (D-F). The 
dashed line in C indicates the epidermis/dermis junction. Scale bars, 25 μm 
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3.2. Fluorescence-activated cell sorting (FACS) as a tool to isolate sensory 
neuron subsets. 
 
When performing immunohistochemical analyses we noticed that the endogenous eGFP 
intensity was quite variable within all the classes of Ret-positive cells. We reasoned that such 
a variability might reflect a further functional diversity among the different Ret-eGFP subsets.  
An optimal method to investigate the distribution of the different intensities of eGFP is 
Fluorescence-Activated Cell Sorting (FACS), which can detect diverse fluorescent signals 
with much more sensitivity than microscopes commonly used to image immunofluorescent 
assays. Importantly, it can also quantify, describe in terms of size and shape complexity and 
physically isolate the cells of interest, keeping them alive. 
FACS is not a technique commonly used in neuroscience: neurons in general, and adult 
sensory neurons in particular, are quite delicate and it is very difficult for them to undergo all 
the processes of isolation, staining and analysis that are necessary for a FACS experiment 
without compromising their integrity. Moreover, the amount of sensory neurons that is 
possible to collect from an animal is very low making FACS analysis of DRG neurons very 
challenging. 
We succeeded in applying the flow cytometric analysis to dissociated neurons isolated from 
Avil-Cre::Ret+/eGFP mice and stained with Isolectin B4. We used IB4 because, among the 
various markers used for Ret-positive neuron characterization, is the only extracellular marker 
and can then be used in live imaging.  
Cells were additionally stained with a marker for hematopoietic cells, cd45, in order to 
identify the immune system cells and eliminate them from the analysis. Furthermore, they 
were stained with a living dye that marks the dead cells that were thus excluded from any 
further quantification and sorting (Figure E1 in part II). 
All the live sensory neurons detected were analysed in terms of eGFP fluorescence intensity 
and IB4 binding. Among the Ret-positive neurons we observed both IB4-positive and IB4-
negative cells, as expected, and also cells with different levels of eGFP fluorescence which 
were clearly grouping to form well-defined, separate subsets. Combining the information 
regarding eGFP intensity level and IB4 binding we could identify at least 5 different 
subpopulations, which we termed Ret-eGFPLo:IB4Neg (A), Ret-eGFPHi:IB4Neg (B), Ret-
eGFPLo:IB4Lo (C), Ret-eGFPHi:IB4Lo (D), and Ret-eGFPHi:IB4Hi (E) (Figure 6 A). 
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Figure 6. A- Flow cytometric analysis of dissociated Avil-Cre::Ret+/eGFP sensory neurons 
plotted according to the level of their eGFP intensity and IB4 binding. We observed 5 well-
defined populations of Ret-eGFP expressing cells. A and B did not bind to IB4 but expressed 
Low and High level of eGFP, respectively. C, D and E did bind to IB4 and displayed a range 
of eGFP intensities. B- eGFP intensity level and IB4 binding were not correlated to the 
median cell size of the different subsets. The graph shows the forward scatter values plotted 
against the normalized number of cells, displayed as the percent of Max. 
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We took advantage of the sorting-function of the FACS to isolate the 2 Ret-positive subsets 
that did not bind to IB4, namely Ret-eGFPLo:IB4Neg (A), Ret-eGFPHi:IB4Neg (B) and perform 
expression profiling. We choose these 2 populations because they were the best defined and 
apparently the most homogeneous among the ones observed: in fact, despite the low amount 
of neurons within these 2 subsets, their distribution fell always down in the same range of 
size, GFP intensity and IB4 binding.  
It is worth noting that the differences that the 2 sorted subpopulations displayed in eGFP 
expression level was not due to a variance in their size, as the range of their size distribution 
was the same (Figure 6 B). 
 
3.2.1. Expression profiling of the sorted subsets 
 
Sorting of the Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg subpopulations was performed in 
replicates. We then isolated RNA from the sorted cells and performed differential microarray 
screening.  
The results from the 2 screenings were compared in order to analyse the genes that were 
differentially expressed between the two samples (Figure 7 A). 
What we first observed, was that Ret expression was 10 fold greater in the Ret-eGFPHi:IB4Neg 
subset compared to Ret-eGFPLo:IB4Neg, consistent with the level of eGFP expression detected 
by FACS. Moreover, we found differential expression of the Gfrα co-receptors: Gfrα3 was 
enriched in Ret-eGFPLo:IB4Neg while Gfrα2 was upregulated in Ret-eGFPHi:IB4Neg. 
Importantly, we found significantly higher level of the mechanosensitive channel Piezo2 
(Fam38b) in the Ret-eGFPHi:IB4Neg subset.  
Interestingly, none of the samples were enriched for TH. 
Thus Ret-eGFPHi:IB4Neg subset displays an up-regulation of Ret, Gfrα2 and Piezo 2: Gfrα2 
has been shown to be the preferred Ret co-receptor in RA mechanoreceptors (Bourane, 
Garces et al. 2009; Luo, Enomoto et al. 2009) and only mechanosensitive neurons should 
express Piezo2. We thus speculate that the Ret-eGFPHi:IB4Neg population might correspond 
indeed to the RA mechanosensitive Ret-positive neurons. 
Regarding Ret-eGFPLo:IB4Neg neurons, they express many other interesting molecules, 
including several with a potential functional role, but almost none of those has been 
previously associated with Ret-positive neurons. 
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Figure 7. Volcano plots of fold change expression in Ret-eGFPLo:IB4Neg versus Ret-
eGFPHi:IB4Neg (A) and versus all DRG neurons (B) against probability. A triple comparison 
between Ret-eGFPLo:IB4Neg, Ret-eGFPHi:IB4Neg and Avil-Cre::R26tdRFPdatasets is also shown 
(D). Itch-associated transcripts (marked in red) were enriched in Ret-eGFPLo:IB4Neg subset, 
as further confirmed by quantitative RT-PCR (D). 
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The only exception is TrkA: expression of this receptor, which we found up-regulated in Ret-
eGFPLo:IB4Neg, has been described in a small subset of adult Ret-positive DRG neurons 
(Golden et al, 2010; Molliver et al, 1997). However the function of this subset is unknown as 
the scarsity of Ret-positive/TrkA-positive neurons have made difficult its further 
characterization. 
Our Ret-eGFPLo:IB4Neg subset displays also other features that have been previously 
annotated, but never fully investigated, in scarce subsets of Ret-positive sensory neurons: for 
example a different level of Ret expression in DRG has already been noticed, and more 
precisely a weak expression of Ret has been associated to Gfrα1 and Gfrα3 co-expression 
(Luo et al, 2007).  
Notably, in Ret-eGFPLo:IB4Neg cells, Gfrα3 is 29 fold up-regulated compared to Ret-
eGFPHi:IB4Neg neurons. 
It is also worth noting that this subset does not bind to IB4, so it is not a nonpeptidergic 
nociceptive population, but on the other hand it does express molecules such as TrkA, CGRP, 
TRPV1 that are known to be absent from Rapidly Adapting or C-fiber Low Threshold 
mechanoreceptors. Consistent with our findings, co-expression of TrkA, CGRP and TRPV1 
has been observed in Ret and Gfrα3-positive sensory neurons and, in addition, it has been 
shown that the majority of Gfrα3-positive cells do not bind to IB4 (Orozco et al, 2001). 
We thus conclude that the Ret-eGFPLo:IB4Neg subset that we isolated corresponds to a new, 
uncharacterized, Ret-positive population, possibly matching the TrkA-positive subset 
mentioned above. Since it is a very small population, this probably explains the lack of 
previous characterization. However, the expression profile of this subset described here 
provides a large amount of information with which to trace the functional identity of this 
population.  
 
3.2.2. Ret-eGFPLo:IB4Neg neurons are putative itch receptors 
 
In order to investigate the function of the new Ret-positive subset, we screened all the genes 
that appeared to be at least two times more expressed in Ret-eGFPLo:IB4Neg compared to Ret-
eGFPHi:IB4Neg, focusing on the ones that displayed the biggest fold change between the two 
samples and on those that could have a functional role in neuronal response, such as ion 
channels, transcription factors, signalling molecules. 
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Surprisingly, we observed that our subset was highly enriched in molecules that have been 
previously implicated in itch perception. For example, we found up-regulation of HRH1 
(histamine receptor 1) that, together with phospholipase-C-beta-3 (Plcb3) and TRPV1 (also 
up-regulated in Ret-eGFPLo:IB4Neg neurons) constitutes part of the pathway responsible for 
histamine-evoked itch (Han et al, 2006).  
Moreover, high expression of the neurotransmitters Nppb and neuromedin B was observed. 
An important role for Natriuretic Polypeptide B (nppb) in spinal itch transmission has been 
recently described, and it has been shown to drive itch sensation arousal from several 
pruritogens (Mishra & Hoon, 2013). Additionally, Nppb is expressed in a subset of small 
unmyelinated, TRPV1-, MrgprA3- and PLCβ-positive sensory neurons, and its receptor Npra 
is found in Lamina I spinal neurons. This is again consistent with our findings as the above-
mentioned markers are all up-regulated in our sample. 
A role for Neuromedin B (Nmb) in itch perception has also been hypothesised as activation of 
its receptor evokes strong pruritus (Sukhtankar & Ko, 2013).  
It is also worth focusing on the enrichment of MrgprA3 in Ret-eGFPLo:IB4Neg. MrgprA3 is 
the receptor for Chloroquine, the antimalarial drug that can provoke itch as side effect. It is 
known that Chloroquine-induced itch follows a non-histaminergic pathway. However, 
MrgprA3 neurons do respond to histamine (Han et al, 2013), which means that they express 
histamine receptors, and coexpression of MrgprA3 and HRH1 is what we observed in Ret-
eGFPLo:IB4Neg subset. However, MrgprA3-positive neurons have been shown to coexpress 
IB4 and CGRP (Han et al, 2013), while in our subset IB4 binding has been excluded. On the 
other hand, CGRP is expressed. 
Importantly, we observed high expression of the co-receptors for Interleukin31, Interleukin 31 
receptor α (IL31RA) and Oncostatin receptor M β (OSMR), which indicates a potential 
clinical relevance for this subset. Indeed high levels of Interleukin 31 in the skin have been 
linked to pathogenesis of Atopic Dermatitis in both human and mice (Dillon et al, 2004; 
Sonkoly et al, 2006). IL-31 is mainly produced by TH2 cells but it directly activates sensory 
neurons, in particular a small subset that coexpress IL31RA, TRPV1 and TRPA1 (Cevikbas et 
al, 2013).  
Considering the identity of the molecules that we found enriched in the Ret-eGFPLo:IB4Neg 
population and their relative combination, we believe we have isolated a small, specific subset 
of Ret-positive cells that has never been characterized before and that this subset is involved 
in itch sensation. 
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3.2.3. Gene expression profiling results are specific for Ret-eGFPLo:IB4Neg 
subset 
 
In our gene expression analysis we considered the genes that were differentially expressed in 
2 populations: Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg. Up-regulation within one of these 
subsets is thus not necessarily linked to specificity of gene expression as some of the 
molecules that I listed above might be expressed as well in populations different from the 
ones that we analysed. 
To overcome this bias, we performed a sorting and expression profiling of total DRG neurons. 
To do so we used Avil-Cre::R26tdRFP mice in which the majority of peripheral sensory 
neurons are marked by RFP fluorescence. 
DRG neurons were isolated from Avil-Cre::R26tdRFP mice and stained in solution with cd45, 
the marker for hematopoietic cells, and a living dye, in order to exclude from the analysis all 
the immune system and all the dead cells, respectively (Figure E3 in part II).  
Only the neurons displaying RFP fluorescence were sorted. The sorting was done on 3 
biological replicates and for each of them we performed expression profiling, namely 
microarray, thus obtaining a dataset of levels of gene expression in total DRG neurons.  
We then compared Ret-eGFPLo:IB4Neg to Ret-eGFPHi:IB4Neg and to this new microarray 
screen (Figure 7 B and C). In general, fold changes appeared lower than for comparisons with 
Ret-eGFPHi:IB4Neg alone, probably reflecting the heterogeneity of total DRG neurons. 
Moreover, some of the genes that in the previous analysis appeared up-regulated in Ret-
eGFPLo:IB4Neg, such as Calca (that encodes for CGRP), are no longer enriched in this subset. 
That is however expected as many genes are expressed in more than one neuronal subset and 
in particular, CGRP is known to be highly expressed in peptidergic nociceptors that form a 
large Ret-negative population: this population is included within the total DRG sample thus 
largely contributing to its level of Calca transcript. 
However, itch-related molecules such as IL31RA, OSMR and nppb are still enriched in Ret-
eGFPLo:IB4Neg subset and this strengthens our hypothesis that these neurons are indeed 
involved in itch sensation. 
Interestingly, we also detected high and specific expression of the two neuropeptides 
somatostatin (sst) and neurotensin (nts).  These have been studied mostly in rats where they 
exert an analgesic effect at the spinal cord level (Sarret et al, 2005; Todd et al, 1998). 
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This new screening provided us with a list of genes that are specifically expressed in Ret-
eGFPLo:IB4Neg neurons and that can be used as markers for this population.  
 
3.2.4. Validation of the gene expression profiling 
 
To validate our microarray analyses, we performed quantitative RT-PCR using a microfluidic 
platform (Fluidigm). 
The cells were collected following the same procedure used for microarray: DRG neurons 
were isolated from Avil-Cre::Ret+/eGFP mice, stained with IB4, cd45 and the living dye Sytox 
Blue and analysed by FACS. Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg subsets were sorted 
and processed for qRT-PCR.  
For the experiment we selected 38 transcripts that we found to be up-regulated in Ret-
eGFPLo:IB4Neg or Ret-eGFPHi:IB4Neg subsets. We chose the genes that represented itch 
associated transcripts, but also ion channels, signalling molecules and transcription factors 
with a demonstrated role in the peripheral nervous system.  
Expression of all of these transcripts was tested in both the samples by using a 48.48 Fluidigm 
Dynamic Array and with technical and biological replicates. Relative expression was 
normalized to GAPDH. 
The results totally confirmed the data obtained by microarray (Figure 7 D and E4 in part II). 
In particular, Ret expression was 10-fold higher in Ret-eGFPHi:IB4Neg subset, as well as eGFP 
expression, thus fully validating the flow cytometry analysis. Moreover, Gfrα2 and Piezo 2 
were up-regulated in this sample, supporting the assumption that it represents the RA 
mechanoreceptors. 
As regards to the Ret-eGFPLo:IB4Neg sample, we found that the highest differential expression 
was for itch-related transcripts, such as the membrane receptors IL31RA, OSMR, HRH1, and 
the neuropeptide nppb, again supporting our previous hypothesis that this population of 
sensory neurons has a role in itch perception. 
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3.3. Functional characterization of Ret-eGFPLo:IB4Neg population 
 
3.3.1. Three functional targets: HRH1, IL31RA and 5-HT1f 
 
Based upon our microarray screening, we hypothesized that Ret-eGFPLo:IB4Neg population 
reflects a new itch-sensitive subset of sensory neurons. To test this assumption we undertook 
a functional characterization of this population concentrating on 3 membrane receptors: 
HRH1, IL31RA and 5-HT1f. 
HRH1 is the histamine receptor preferentially expressed in pruriceptors. Histamine is the most 
widely used pruritogen in the experimental induction of itch. However it is naturally produced 
by many cell types and in particular by mast cells in case of tissue inflammation or allergic 
stimulation. 
We selected HRH1 for our functional analysis because, even though it has been widely 
studied, it has never been observed in Ret-positive cells. Moreover, functional assays for 
histamine are well assessed and we used it as a positive control for our other investigations. 
IL31RA is the receptor for Interleukin31, which has a demonstrated role in the pathogenesis 
of atopic dermatitis. This is one of the most common itch associated diseases, with a 
prevalence of 2-5%. It is an inflammation of the dermis and the epidermis, chronically 
relapsing, causing an intense itch and thus affecting enormously the quality of life of the 
affected people. Antihistamines are used for relief, but their efficacy is limited and to date a 
fully efficient long-term therapy is unfortunately lacking. 
Sensory neurons expressing Interleukin 31 receptor are therefore potential clinical targets. We 
have a dataset of transcripts that are enriched in a subset of sensory neurons that might be 
involved in atopic itch perception: if we demonstrate this involvement we could immediately 
start searching for a pharmacological target. 
When screening the expression profile data we also noticed that a serotonin receptor, namely 
5-HT1f (also known as Htr1f), was among the most highly expressed transcripts in Ret-
eGFPLo:IB4Neg population compared to both Ret-eGFPLo:IB4Neg and total DRG neurons, 
expression that was also validated by Fluidigm. 
Serotonin is pruritogenic and injections in the skin of mice provoke scratching (Akiyama et al, 
2009). Several serotonin receptors exist, but a role in itch has been assessed so far only for 5-
HT2 (Yamaguchi et al, 1999). 5-HT1f is a receptor that couples to the inhibition of adenylate 
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cyclase (Adham et al, 1993), so we reasoned that its activation could lead to inhibition of Ret-
eGFPLo:IB4Neg neuronal activity. 
Importantly, a selective agonist for 5-HT1f is available, LY344864, which can be used for 
functional characterization of these neurons 
 
3.3.2. Functional characterization strategy 
 
To assess the function of Ret-eGFPLo:IB4Neg neurons, we decided to perform first calcium 
imaging experiments on cultured neurons isolated from Avil-Cre::Ret+/eGFP mice. Calcium is 
an essential intracellular messenger in mammalian neurons and its concentration rises during 
their electrical activity. Through calcium imaging techniques it is possible to monitor the 
intracellular calcium increase in cultured cells and thus detect activated neurons. For our 
experiments we used the calcium indicator Fura-2AM, a membrane-permeable ratiometric 
fluorescent dye. It is excitable by ultraviolet light at 340 nm and 380 nm and the ratio of the 
emissions at those wavelengths is directly correlated to the amount of intracellular calcium, 
and thus neuronal activation. 
We cultured neurons from Avil-Cre::Ret+/eGFP mice and stained them with Isolectin B4. 
Unfortunately the sensitivity of the microscope was not high enough to distinguish in an 
objective way different levels of Ret expression, so we concentrated on 3 neuronal subsets: 
Ret-eGFP/IB4-negative, Ret-eGFP/IB4-positive and Ret-eGFP-negative cells 
We then loaded the cells with Fura-2AM and applied histamine, IL-31 or LY344864 via 
perfusion. The cells that were activated by each compound had an increase of intracellular 
calcium that provoked a switch in the emission peak of Fura-2AM and an increase in the 
380/340 ratio. We could then determine the proportion and the identity, in terms of eGFP 
expression and IB4 binding, of the cells responsive to each of the above-mentioned 
compounds. 
We sought to explore the function of Ret-eGFPLo:IB4Neg neurons also in vivo. To do so we 
injected into the nape of Avil-Cre::Ret+/eGFP mice histamine, IL-31 or LY344864 and 
monitored the scratching behaviour that each of the substances evoked. Each animal was 
recorded for 30 minutes after the injection and bouts of scratching were counted.  
In addition, we assessed the induction of c-fos expression in spinal cord slices. Upregulation 
of C-fos in spinal cord interneurons indicates recent cell activity, so it represents an indirect 
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marker of neuronal activation and indicates where the central afferents of our subset terminate 
within the dorsal horn of the spinal cord.  
 
3.3.3. Histamine and HRH1 
 
We first investigated the activation of Ret-eGFP/IB4-negative cells by histamine. After 
culturing DRG neurons isolated from Avil-Cre::Ret+/eGFP mice, staining them with IB4 and 
loading them with Fura-2AM ,we performed calcium imaging.  
When we perfused the cells with histamine, we saw that 9,7% of all neurons were activated 
(542 total cells). Among these, we assessed the proportion of Ret-eGFP/IB4-negative, Ret-
eGFP/IB4-positive and Ret-eGFP-negative cells and we found that 54% of the responding 
cells belonged to the Ret-eGFP/IB4-negative subset, confirming that some cells that express 
Ret but do not bind to IB4 are actually activated by histamine (Figure 8A). The fact that we 
found responding cells also within the other 2 subsets is not surprising as histamine can act on 
several neuronal populations. 
We then performed an in vivo analysis by injecting subcutaneously 8 wild-type or Avil-
Cre::Ret+/eGFP mice with 1µM histamine. The mice injected with histamine scratched much 
more than controls injected with saline, as expected (Figure 8A in part II). We then collected 
the cervical part of the spinal cord of the Avil-Cre::Ret+/eGFP mice treated with histamine and 
performed c-fos staining. We observed a widespread activation of spinal cord interneurons 
mainly located in superficial lamina I of the dorsal horn and in lamina III and few of them 
were overlapping with eGFP (Figure E6 A-D in part II). Therefore, we can conclude that 
some of the Ret-eGFP/IB4 negative neurons do respond to histamine. 
There is a long-standing debate about the coexistence within the same cells of histaminergic 
and non-histaminergic pathways. In our subset we found high expression of both HRH1 and 
MrgprA3: the latter is the receptor that mediates chloroquine response, which occurs through 
a non-histaminergic pathway (Wilson et al, 2011). The histamine and chloroquine receptors 
function through activation of TRPV1 and TRPA1 channels respectively. We thus performed 
calcium imaging on Avil-Cre::Ret+/eGFP neurons with chloroquine, capsaicin (the TRPV1 
agonist) and allyl isothiocyanate (AITC, the TRPA1 agonist). The three compounds activated 
a broad range of DRG neurons, including Ret-eGFP/IB4 negative cells (Figure 8 B-D). In 
particular, 72% of the neurons that responded to chloroquine (475 total cells) belonged to that 
population. This data support the idea that histamine-dependent and histamine-independent 
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pathways might coexist within the same neurons. A convergence of these different 
mechanisms has been shown in a subset in trigeminal ganglia (Roberson et al, 2013) which 
could be the correlate of Ret-eGFP/IB4-negative in the DRG. 
 
 
 
Figure 8. Calcium imaging was performed on dissociated Avil-Cre::Ret+/eGFP neurons. Here 
we show the proportions of responding cells that were Ret-eGFP/IB4 negative, Ret-eGFP/IB4 
positive and Ret-eGFP negative. Histamine and Chloroquine (A and B, respectively) activate 
mostly Ret-eGFP/IB4- negative neurons. AITC (C) activates predominantly IB4-positive 
neurons, while capsaicin (D) mainly IB4-negative cells. 
 
 
3.3.4. Interleukin 31 and IL31RA 
 
As mentioned above, Interleukin 31 is a clinically important molecule because of its 
involvement in the pathogenesis of atopic dermatitis. We first examined the expression of its 
receptor IL31RA in DRG neurons. There are no dedicated antibodies that work for 
immunofluorescence, so we used an active, fluorescently labelled IL-31 molecule to mark 
IL31RA positive cells. This consisted of a mono-biotinylated IL-31 conjugated with 
streptavidin alexa-fluor 546 that was applied directly to cultured Avil-Cre::Ret+/eGFP neurons. 
A small subset of cells was marked: the majority was represented by neurons that weakly 
expressed Ret and did not bind to IB4, thus confirming our microarray data (Figure 9 A-D). 
As a further proof we performed calcium imaging on Avil-Cre::Ret+/eGFP neurons, using 2nM 
of IL-31. We demonstrated that a small subset of neurons (5,6% of all neurons, 502 total 
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cells) was robustly activated by IL-31 and the majority of those (83,9%) were Ret-eGFP/IB4 
negative cells (Figure 9 E-H).  
This result indicates, as recently shown (Cevikbas et al, 2013) that IL-31 may function by 
directly activating sensory neurons: we further believe that it activates in particular a subset 
that expresses Ret but does not bind to IB4. This activation could then be the first step in 
transducing an inflammatory cascade into a behavioural response, which in this case would be 
scratching.  
A similar finding has been recently made for another cytokine, thymic stromal lymphopoietin 
(TSLP) that acts directly on sensory neurons to produce robust scratching (Wilson et al, 
2013). TSLP has also been suggested to trigger initiation and maintenance of Atopic 
Dermatitis, but it activates a subset of sensory neurons that was not sensitive to either 
histamine or chloroquine. Moreover TSLP receptor transcripts (Il7r and crlf2) were not 
enriched in our Ret-eGFPLo:IB4Neg subset, thus excluding that the 2 populations might 
coincide.  
We also sought to examine the role of IL-31 in vivo. We injected 8 wild type or Avil-
Cre::Ret+/eGFP mice with 55pM IL-31 into the nape of the neck and counted the bouts of 
scratching in the 30 minutes following the injection. A single low dose of the cytokine was 
enough to provoke robust scratching (Figure 10) 
Cervical spinal cord from Avil-Cre::Ret+/eGFP mice injected with IL-31 was collected after the 
behavioural test and c-fos staining was performed. C-fos expression was sparse and involved 
few cells, the majority of which were in Lamina I (Figure 8B in part II). 
 
3.3.5. LY344864 and 5-HT1f  
 
Serotonin acts through a variety of membrane-bound receptors that are found in both central 
and peripheral nervous system, as well as non-neuronal tissues such as gut, cardio-vascular 
system and blood (Hoyer et al, 2002). 
In mouse DRG neurons only 5-HT2 has been previously implicated in itch sensation 
(Yamaguchi et al, 1999). We found a very high expression of another serotonin receptor 
transcript, 5-HT1f, in Ret-eGFPLo:IB4Neg subset. 
We performed calcium imaging on cultured sensory neurons from Avil-Cre::Ret+/eGFP mice, 
stained with IB4, by applying 30 nM LY344864. Surprisingly, we observed that a population 
of neurons was activated. 
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Figure 9.  Biotinylated IL-31 binds to cells that weakly express Ret-eGFP and do not bind to 
IB4 (A-D). It also elicits neuronal response when used in calcium imaging (E-G), especially 
in Ret-eGFP/IB4 negative sensory neurons (H). LY344864 can drive neuronal activation as 
well (I-M) and the majority of activated DRG neurons were Ret-eGFP/IB4 negative (N). 
 
 
Figure 10. Histamine, IL-31 and 
LY344864 cause scratching in vivo 
after single injection. Animals 
were observed for 30’ aftert the 
injections and the number of bouts 
of scratching was always 
significantly bigger compared to 
what observed in animals treated 
only with vehicle. 
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The main reason we chose this receptor as a target is because it is coupled to Gi signalling 
which should inhibit neuronal activation, so we did not expect to observe calcium influx in 
any neuronal subset. Instead we observed neuronal firing in 3,5% of total neurons (292 total 
cells) and 70% of these were Ret-eGFP/IB4-negative (Figure 9 I-N). Intriguingly, it has been 
reported that many Gi coupled receptors can interact with a G14 subunit that has the capacity 
to link Gi coupled receptors to activation of PLCβ (Ho et al, 2001). Notably, the G14 subunit is 
encoded by Gna14 gene and we found its transcript to be among the most differentially 
expressed in Ret-eGFPLo:IB4Neg population. Its presence could therefore expand the signalling 
repertoire of this subset and explain why neuronal activation through 5-HT1f occurs. 
We investigated further the effect of LY344864 in vivo by injecting it in 7 wild-type or Avil-
Cre::Ret+/eGFP mice at a 1mM concentration. We detected a number of bouts of scratching in 
the 30 minutes following the injection that was significantly higher than what we observed in 
control mice injected with saline (Figure 10). We therefore believe that activation of 5-HT1f 
receptor in DRG neurons triggers itch and that this happens in a subset of Ret-eGFP/IB4 
negative population. 
We collected the cervical part of the spinal cord of Avil-Cre::Ret+/eGFP mice injected with 
LY344864 and checked for c-fos immunoreactivity: we detected a few interneurons positive 
for anti-c-fos antibody located mainly in Lamina I and III (Figure 8B in part II). 
It is worth mentioning that this serotonin receptor has been proposed as clinical target in the 
treatment of migraine (Goadsby, 2005): such a 5-HT1f based drug, however, could activate 
Ret-eGFPLo:IB4Neg population causing itch as a side effect. 
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3.3.6. Role of Ret-eGFPLo:IB4Neg neurons in itch sensation 
 
Our calcium imaging and scratching behaviour analyses point towards the fact that subsets of 
Ret-eGFP/IB4-negative neurons are activated by pruritogens. Histamine is a well-known 
itching substance but it has never been observed to act on neurons that express Ret but do not 
bind to IB4. Here we show that such activation occurs. The interaction of interleukin 31 with 
its receptor IL31RA on DRG neurons has been recently described (Cevikbas et al, 2013) but it 
is the first time that Ret-positive and IB4-negative neurons are being involved in a pruritic 
stimulus detection that is linked to atopic dermatitis. As regards the serotonin agonist 
LY344864, we demonstrated that it acts as an itch promoting compound, thus discovering 
both a new receptor, 5-HT1f, and a new sensory neuron subset involved in pruritus. 
Our microarray data indicate that it is the Ret-eGFPLo:IB4Neg subset of sensory neurons that 
mediates response to Histamine, IL-31 and LY344864. We were however not able to directly 
address this as we could not objectively target Ret-eGFPLo:IB4Neg cells but a bigger Ret-
eGFP/IB4-negative population which also includes Ret-eGFPHi:IB4Neg neurons. Therefore, we 
sought to specifically target Ret-eGFPLo:IB4Neg neurons by using a genetic approach: among 
the transcripts specifically enriched in this subset, according to the microarray data, we found 
that somatostatin (sst) was highly expressed in this population. Given its function as 
neuropeptide and especially the availability of a Sst-Cre driver line, we choose it as a target 
gene for further analyses. 
 
3.4. First characterization of Sst-Cre::ReteGFP mice 
 
Somatostatin is a peptide produced by neurons and other cell types. It has been originally 
discovered as the hypothalamic growth hormone release-inhibiting hormone (Siler et al, 1973) 
but soon expression in tissues other than central nervous system was reported (Hokfelt et al, 
1975). Somatostatin is also expressed in dorsal root ganglia and it has been shown that in rats, 
it exerts an inhibitory action on dorsal horn neurons (Chapman & Dickenson, 1992) and, in 
particular, an anti-nociceptive and anti-inflammatory effect. Moreover, it relieves pain in 
humans (Shi et al, 2014). Because we found that somatostatin was enriched in our Ret-
eGFPLo:IB4Neg population, we reasoned that having a mouse line where somatostatin drives 
Cre expression could allow us to exclusively target this subset. 
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We obtained an Sst-ires-Cre driver line (Taniguchi et al, 2011) and crossed it with the 
ReteGFP/+ line. In this way we should observe eGFP fluorescence in cells that express both Sst 
and Ret and therefore specifically mark Ret-eGFPLo:IB4Neg neurons. We were expecting to 
see only few fluorescent neurons, given the low amount of cells belonging to this subset, and 
expressing eGFP at low level. 
Indeed, we observed when we performed immunohistochemistry on DRG sections from Sst-
Cre::ReteGFP mice that eGFP-positive cells constituted 1,3 ± 0,28 percent of the total number 
of neurons (3 adult mice, 8820 tot cells) and eGFP endogenous expression appeared quite 
faint, comparable with the palest fluorescence detected in DRG from Adv-Cre::ReteGFP. 
We performed stainings with NF200, IB4 and TH in order to identify mechanoreceptors, non-
peptidergic nociceptors and C-fiber low threshold mechanoreceptors, respectively, and 
exclude that the eGFP-positive cells belong to any of these populations (Figure 11) .  
The vast majority of eGFP-positive cells (87,5 ± 8,9 percent) did not coexpress any of the 
above-mentioned markers, confirming our hypothesis that these neurons belong to a new 
uncharacterized subset of Sst-positive and Ret-positive cells.  
 
 
 
 
Figure 11. A small proportion of DRG neurons from Sst-Cre::ReteGFP mice displays eGFP 
fluorescence (1,6 ± 0,28 percent of total cells) which in 87,5 ± 8,9 percent of the the neurons 
does not overlap with IB4, NF200 or TH. Scale bars: 50 µm. 
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We could not detect the precise central patterns of innervation of the Sst-Cre::ReteGFP DRG 
neurons due to the fact that the paucity of the fluorescent afferent fibers was overwhelmed by 
Sst-expressing interneurons: in fact somatostatin expression has been detected also in spinal 
cord interneurons (Proudlock et al, 1993). As regards the peripheral projections of Sst/Ret-
eGFP positive neurons, we detected faint fluorescence at the dermal/epidermal border, 
forming free nerve endings (Figure 6 I-L). 
To strengthen our analysis and see whether the Sst-ires-Cre line could be used to 
unequivocally mark the Ret-eGFPLo:IB4Neg population, we investigated whether somatostatin 
expression in DRG is actually confined to a subset of Ret-positive cells. The fact that we 
found somatostatin transcript to be up-regulated in Ret-eGFPLo:IB4Neg subset compared to 
total DRG neurons, in fact, does not automatically exclude a potential low-level expression in 
other cell subtypes. Therefore we crossed the Sst-ires-Cre line with a Rosa-tdRFP strain to 
obtain Sst-Cre::R26tdRFP mice that have all the sst-expressing neurons marked with RFP 
fluorescence.  
We quantified the number of RFP-positive sensory neurons and found the similar percentages 
observed for eGFP-positive cells from Sst-Cre::ReteGFP DRG. Namely, the cells expressing 
RFP were 1,86 ± 0,74 percent of total sensory neurons (3 adult mice, 3300 tot. cells), which 
was not statistically different from the proportion of Sst/Ret-eGFP-positive cells (student’s t-
test, p-value=0,19) (Figure 12). We further stained DRG with NF200, IB4 and TH and again 
we found similar distribution of overlaps detected for Sst/Ret-eGFP-positive cells. We thus 
believe to have now the tools to specifically target the Ret-eGFPLo:IB4Neg subset by using the 
Sst-ires-Cre: this will simplify any further analysis and characterization of this population. 
 
 
Figure 12. DRG section from Sst-Cre::R26tdRFP mouse stained with RFP, IB4 and NF200. 
Sst/RFP-positive cells were 1,86 ± 0,74 percent of total cells, and 84,4 ± 4,13 percent of them 
did not stain with IB4 or NF200. We could not perform TH staining because of the 
incompatibility of the antibodies. Scale bar: 50 µm. 
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4. Conclusions and future prospects 
 
During my PhD work I developed methods for applying flow cytometric techniques to Dorsal 
Root Ganglia neurons, thus proposing a new way of isolating and characterizing discrete 
sensory neuron subpopulations. Flow cytometry has not been used so far to analyse sensory 
neurons due to the fragility of these cells and their low number within the organism. However 
I demonstrated that this technique is not only feasibly appliable on DRG neurons, but it can 
provide data that are not acquirable with the common techniques used in the somatosensory 
field. Indeed, by using FACS, it is possible to isolate discrete subsets of cells, even those that 
are numerically very small and thus almost undetectable with immunohistochemistry, and to 
obtain their gene expression profiles. The knowledge of the type of transcripts that are 
enriched in a given population opens a lot of possibilities regarding its functional 
characterization thus easing the understanding of the systems biology of sensory neurons. 
I applied these techniques to Avil-Cre::ReteGFP DRG neurons bringing new insights into Ret-
expressing neuron function and distribution. I isolated 2 Ret-positive subsets that displayed 
different levels of eGFP fluorescence and did not bind to IB4. Their expression profiles 
indicated that one of them, namely Ret-eGFPHi:IB4Neg subset, probably represents the RA 
mechanoreceptive subset of Ret-positive cells, while the second one, Ret-eGFPLo:IB4Neg 
subset, is likely to be a new population involved in itch perception. This assumption was 
made based on the type of transcripts that we found up-regulated in the 2 subsets. In fact, 
many of the genes enriched in Ret-eGFPLo:IB4Neg neurons have been linked, in previous 
researches, to itch sensation.  
We functionally characterized this population by focusing on 3 molecules whose receptors 
were specifically expressed in the putative itch subset: histamine, IL-31 and the agonist of the 
serotonin receptor 5-HTif, LY344864. By performing calcium imaging, we demonstrated that 
all the three substances could activate a subset of Ret-eGFP/IB4-negative cells. Notably, for 
none of the compounds a role in Ret-positive subset activation has been observed before. It is 
also interesting that 5-HT1f, despite being a Gi coupled receptor, could provoke a neuronal 
response. 
We further analysed the function of the three compounds in-vivo, by injecting them in the 
neck of the mice and assessing scratching behaviour. While for histamine and IL-31 a direct 
role in pruritus processing has already been assessed, this was not the case for LY344864. My 
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data indicates that it actually does provoke itch, therefore discovering a new serotonin 
receptor involved in itchy sensation. 
By genetically marking with Sst-Cre::ReteGFP mice exclusively the Ret-eGFPLo:IB4Neg subset, 
we further demonstrated that there is a sensory neuron population that expresses Ret and does 
not bind to any of the markers known to be coexpressed in Ret-positive neurons. 
In addition to the scientific implications of these findings, we also believe that the new Ret-
positive subset could be of clinical importance. For example, IL-31-driven activation 
underlines the potential role of these neurons in the pathogenesis of atopic itch. Moreover 
while the fact that 5-HTif receptor also drives pruritic response must be considered by the 
researchers that have proposed that receptor as a target for migraine treatments as they could 
provoke side effects.  
It is also worth noting the coexistence within this new subset of the histamine receptor with 
molecules that have been described as initiators of histamine-independent itch pathways, such 
as MrgprA3. It is still under debate whether these mechanisms act in different subpopulations 
of sensory neurons or they can also be simultaneously present in the same cells. Our findings 
argue against a complete separation of the two pathways within DRG neurons. 
A further important observation stems from the small amount of neurons that belong to the 
population we discovered: despite their scarcity, they are able to elicit scratching behaviour, 
which suggests that many other small but functionally important DRG subsets might exist that 
have likely never been detected by the commonly used techniques. They could be identified, 
however, by flow cytometry. 
In further work exploring this population, we have demonstrated that we now have a good 
tool to examine deeply the new Ret-positive subpopulation: the Sst-ires-Cre mouse line. First 
of all, we are planning to perform FACS on these mice in order to sort the eGFP+ cells and 
check specific gene expression by quantitative RT-PCR (Fluidigm) with the aim of comparing 
it to the results obtained from Ret-eGFPLo:IB4Neg subset and see whether they coincide. 
Preliminary results with FACS showed that Sst/Ret-eGFP-positive neurons follow a 
distribution, in terms of numbers, size and eGFP intensity, which is very similar to Ret-
eGFPLo:IB4Neg subset. Sst-Cre::ReteGFP mice could be further characterized with calcium 
imaging experiments to prove that Sst/Ret-eGFP–positive cells do respond to histamine, IL-
31 and LY344864. The experiment that would ultimately confirm the role of our Ret-positive 
subset in itch sensation is ablation of these neurons. Our study suggests that somatostatin is 
specifically expressed in the new subpopulation, therefore the Sst-ires-Cre line could be used 
to specifically drive its ablation, for example, by crossing it with a line that expresses the 
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diptheria toxin receptor after Cre recombination and specifically in DRG neurons. Functional 
analyses would then assess whether sensory neurons still respond to IL-31 and LY344864 and 
wheter scratching behaviour following injections of those substance is reduced, thus 
confirming, or not, our hypothesis. 
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ABSTRACT 
Itch, the unpleasant sensation that elicits a desire to scratch is mediated by specific 
subtypes of cutaneous sensory neuron. Here, we identify a subpopulation of itch sensing 
neuron that express the receptor tyrosine kinase Ret. We applied flow cytometry to 
isolate Ret positive neurons from dorsal root ganglia (DRG) and detected a distinct 
population marked by low levels of Ret expression and absence of isolectin B4 (IB4) 
binding. We determined the transcriptional profile of these neurons and demonstrate 
that they express neuropeptides, the NGF receptor TrkA, and multiple transcripts 
associated with itch. Neurons in this population were responsive to both histamine and 
histamine-independent itch stimuli. Moreover, interleukin 31 (IL-31), a cytokine with a 
prominent role in atopic dermatitis, and agonists at the 5HT1F receptor, directly 
activated these cells and evoked robust scratching behavior. Our data provide a 
molecular signature for a subpopulation of neurons activated by multiple pruritogens.   
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INTRODUCTION 
The perception of physical and chemical stimuli through the skin is initiated by peripheral 
sensory neurons that have their cell body in the DRG. The complexity of somatosensation is 
reflected by the fact that a myriad of sensations including touch, pain, itch and temperature 
are recognized by the peripheral nervous system. It has long been debated whether this 
functional complexity arises from activation of specific subtypes of sensory neuron for each 
stimulus modality, or from encoding and summation of neuronal activity generated by 
neurons that can detect a broad range of stimuli (Ma, 2010). Recently, it has been proposed 
that the sensation of itch is a discrete sensory modality that utilizes a dedicated neuronal 
pathway tuned to perceive only this sensation (Han et al, 2013; Mishra & Hoon, 2013; Sun et 
al, 2009).  
Itch, the sensation that elicits a desire to scratch, serves a protective function against 
potentially harmful environmental irritants (Ikoma et al, 2006). Although unpleasant, itch is 
inherently different from pain, both in its sensory quality and its behavioral outcome 
(scratching compared to withdrawal). The neuronal pathways that mediate itch versus pain 
also appear to be distinct. In the spinal cord, ablation of neurons expressing receptors for the 
neuropeptides gastrin-releasing peptide (Grp) (Sun et al, 2009) or Natriuretic polypeptide b 
(Nppb) (Mishra & Hoon, 2013) reduces itch responses to multiple pruritogens but does not 
affect nociceptive behavior. Similarly, subpopulations of C-fiber primary afferents are 
activated by pruritogens (Davidson et al, 2007; Schmelz et al, 1997; Schmelz et al, 2003) and 
ablation or selective activation of DRG neurons positive for the Mas-related G protein 
coupled receptor A3 (MrgprA3) impacts upon scratching behavior but not pain (Han et al, 
2013). 
Itch is further categorized by its dependence upon histaminergic or non-histaminergic 
mechanisms. Histamine-dependent itch is elicited through activation of the H1 receptor 
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(HRH1) and signaling through phospholipase-β3 (PLCβ3) and the ion channel TRPV1 (Han 
et al, 2006; Imamachi et al, 2009). The existence of further histamine-independent pathways 
is supported by observations that many chronic pruritic syndromes such as atopic dermatitis 
are resistant to antihistamine therapy (Yosipovitch & Papoiu, 2008). Mechanistically, 
histamine-independent itch is likely to be mediated by activation of the ion channel TRPA1. 
For example, injection of the antimalarial agent chloroquine induces itch (Ajayi et al, 1989) 
via MrgprA3 receptors (Liu et al, 2009) functionally coupled to TRPA1 (Wilson et al, 2011), 
and TRPA1 is also required for itch produced by oxidative stress and leukocyte accumulation 
(Fernandes et al, 2013; Liu & Ji, 2012). Other antihistamine resistant itch responses include 
those elicited by cytokines such as interleukin 31 (IL-31) released from T-cells during allergic 
itch (Akiyama & Carstens, 2013; Cevikbas et al, 2013). IL31 induces severe pruritus and may 
be a key mediator in atopic dermatitis (Dillon et al, 2004), although the mechanism by which 
it activates distinct neuronal itch pathways is unknown.  
While histamine-dependent and independent itch utilize distinct molecular mechanisms to 
activate neurons, it is unclear whether this occurs in discrete populations of sensory neuron. 
All MrgprA3 expressing neurons respond to histamine (Liu et al, 2009) and ablation of these 
cells reduces histamine-evoked scratching (Han et al, 2013). However, it has also been 
reported that histamine and non-histamine evoked itch occurs in separate peripheral pathways 
(Davidson et al, 2012), and indeed silencing of TRPV1 or TRPA1 positive neurons selectively 
inhibits histamine or chloroquine evoked itch respectively (Roberson et al, 2013). Further 
information on the molecular profile of subpopulations of sensory neurons and identification 
of molecular markers for different subtypes of itch neuron would resolve these conflicting 
observations.  
To distinguish different populations of sensory neuron and ultimately define their function we 
examined the expression pattern of the glial-derived neurotrophic factor (GDNF) receptor Ret 
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in mouse DRG. Almost every DRG neuron expresses at least one neurotrophic factor 
(Marmigere & Ernfors, 2007), and approximately 60 percent of cells are marked by Ret 
(Molliver et al, 1997). The Ret tyrosine kinase is the signaling receptor for GDNF family 
ligands GDNF, neurturin, artemin and persephin which bind via GPI-anchored co-receptors 
termed GFRα1-4 to initiate signaling through Ret (Airaksinen & Saarma, 2002). Two distinct 
waves of Ret expression arise during development with the first occurring prior to E11.5 and 
the second emerging subsequently (Luo et al, 2007; Molliver et al, 1997). Early Ret positive 
neurons develop into rapidly adapting mechanoreceptors and express the co-receptor GFRα2 
and high levels of Ret (Bourane et al, 2009; Luo et al, 2009).  Late Ret positive neurons form 
a large heterogeneous group of non-peptidergic nociceptors that can be distinguished by their 
binding of the plant lectin IB4 (Luo et al, 2007; Molliver et al, 1997). A further population of 
Ret positive neuron co-expresses the enzyme tyrosine hydroxylase (TH) (Franck et al, 2011; 
Li et al, 2011) and forms C-fiber low threshold mechanoreceptors which have been implicated 
in the affective component of touch (Olausson et al, 2010). Ret signaling is required for the 
differentiation, maturation and anatomical projections of these populations indicating that it 
has powerful regulatory actions on primary sensory neurons (Bourane et al, 2009; Franck et 
al, 2011; Golden et al, 2010; Honma et al, 2010; Luo et al, 2009; Luo et al, 2007; Molliver et 
al, 1997).  
We sought to define functionally distinct populations of Ret-positive neuron by first 
examining Ret co-expression with conventional markers in the DRG and then determining the 
molecular profile of identified populations to establish their function. To this end we took a 
genetic approach and generated mice where eGFP expression was driven from the Ret locus 
exclusively in peripheral sensory neurons (Jain et al, 2006; Zurborg et al, 2011).  We 
identified multiple subpopulations of Ret-positive neurons in DRG which were quantified 
using flow cytometry. Microarray analysis of Ret expressing neurons that were negative for 
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IB4 uncovered a rare population of cells enriched for pruritogen receptor transcripts. 
Characterization of these neurons revealed a novel subtype of Ret-positive neuron selectively 
activated by multiple classes of pruritogen. 
 
RESULTS 
Ret-eGFP expression in primary sensory neurons 
To examine Ret expression in the adult peripheral nervous system, ReteGFP/+ mice (Jain et al, 
2006) were crossed with Avilcre/+ mice to obtain heterozygote Avil-Cre::ReteGFP/+ mice. This 
approach allowed us to target all DRG neurons and avoid extraneous GFP expression in 
surrounding tissues (Zurborg et al, 2011). Heterozygous mice were viable, exhibited no overt 
behavioural phenotype, and displayed robust eGFP fluorescence in peripheral sensory 
ganglia.  
We investigated Ret-eGFP distribution in DRG by co-staining sections from Avil-
Cre::ReteGFP/+ mice with a selection of markers for different subtypes of sensory neuron. Ret-
eGFP was present in 55±3 percent of neurons (n=12 DRG cultures) and displayed a broad 
range of fluorescence intensities across different cells. We examined expression with IB4 and 
NF200, markers of non-peptidergic nociceptors and myelinated neurons respectively, and 
observed overlap with the majority of Ret-eGFP positive neurons (Figures 1A-1D), reflecting 
the early and late Ret neurons described previously (Luo et al, 2007; Molliver et al, 1997). We 
further investigated Ret-eGFP co-expression with TH, a marker of C-fiber low threshold 
mechanoreceptors (Franck et al, 2011; Li et al, 2011). eGFP fluorescence was evident in 
many TH-positive neurons and these cells were not co-labeled with NF200 or IB4 (Figures 
1E-1L). Our analysis also indicated that a small proportion of Ret-eGFP positive neurons 
were not marked by either IB4, NF200 or TH suggesting the existence of a novel subtype of 
Ret expressing neuron. To characterize this population, we co-stained sections with CGRP, a 
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marker of peptidergic nociceptors that has not been previously associated with Ret-positive 
sensory neurons. Intriguingly, Ret-eGFP fluorescence coincided with a small proportion of 
CGRP expressing cells (Figures 1M-P) that may reflect a functionally uncharacterized subset 
of primary afferent neuron.  
We utilized Avil-Cre driven Ret-eGFP expression to examine the peripheral and central 
projections of Ret-positive sensory neurons. In the skin Ret-eGFP fluorescence was broadly 
distributed and present in free nerve endings terminating in the dermis and epidermis (Figures 
2A-2C), and in lanceolate endings encircling hairs (Figures 2D-2F). Similarly in spinal cord 
sections, Ret-eGFP was widely expressed across the dorsal horn. This was evident as a dense 
plexus of expression in lamina IIo corresponding to IB4 positive non-peptidergic nociceptors 
(Figures 3A-D and I-L) and more diffusely through laminae III to V overlapping with NF200 
labeled mechanoreceptor inputs (Figures 3E-H). Notably, we also detected Ret-eGFP 
expression immediately ventral to IB4 positive terminals that coincided with PKCγ, a marker 
for lamina IIi/III interneurons (Figures 3A-H), and in lamina I co-expressed with CGRP. Thus 
RET-eGFP expression distinguishes multiple populations of peripheral sensory neuron that 
are likely to be functionally distinct.  
To obtain quantitative data on the distribution of Ret positive neuronal populations in DRG 
we applied flow cytometric analysis to acutely dissociated neurons. We focused on levels of 
IB4 binding and native Ret-eGFP fluorescence as this would allow for quantitative 
measurements in live cells. In line with histological data, we observed both IB4-positive and 
IB4-negative populations of Ret-eGFP neuron (Figures 4A and E1). Importantly however, 
flow cytometric analysis revealed multiple well-defined subpopulations delineated by their 
levels of eGFP fluorescence and IB4 binding (termed Ret-eGFPLo:IB4Neg (A),  Ret-
eGFPHi:IB4Neg (B), Ret-eGFPLo:IB4Lo (C), Ret-eGFPHi:IB4Lo (D), and Ret-eGFPHi:IB4Hi (E)). 
There was a broad distribution in cell size across all populations as determined by forward 
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scatter values, and no correlation between size and levels of IB4 binding or fluorescence 
(Figure 4B). We further validated flow cytometric analysis using fluorescent microscopy and 
observed that in both sensory neuron cultures (Figure 4C) and sections of DRG (Figure 4D) 
from Avil-Cre::Ret+/eGFP mice, native eGFP fluorescence varied by an order of magnitude 
across IB4 positive and negative cells. 
 
Transcription profiling of Ret-eGFP, IB4 negative neurons 
We reasoned that by defining the molecular composition of Ret-eGFP populations we may be 
able to gain clues as to their function. We focused on IB4-negative neurons because flow 
cytometric data indicated that these cells formed two well defined and potentially 
homogeneous populations. Moreover, while one of these populations presumably corresponds 
to RA mechanoreceptors (Bourane et al, 2009; Luo et al, 2009), the other may reflect an as 
yet uncharacterized population of Ret-positive neurons. We performed differential microarray 
screening on sorted Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg cells and determined that these 
two populations do indeed cluster into distinct, homogeneous subsets (Figure E2). We further 
identified several functional markers in each population that gave a first indication as to their 
identity. For example, Ret-eGFPLo:IB4Neg cells were enriched in transcripts for TRPV1, 
CGRP (Calca), and the Ret co-receptors GFRα1 and GFRα3, (Figure 5A), while Ret-
eGFPHi:IB4Neg neurons expressed significantly higher levels of Ret, GFRα2, and the 
mechanosensitive ion channel Piezo 2 (Fam38b) (Figure 5A). Intriguingly, neither population 
was enriched for TH. We thus speculate that Ret-eGFPHi:IB4Neg neurons may correspond to 
RA mechanoreceptors, while Ret-eGFPLo:IB4Neg cells represent a novel, functionally distinct 
subtype of nociceptor.   
We sought to define the function of the novel Ret-eGFPLo:IB4Neg population and observed 
that this subset was highly enriched in molecules previously implicated in itch (Figure 5A, red 
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dots). For example, transcripts for histamine-dependent itch mediators HRH1, PLCβ3 and 
TRPV1 were all differentially expressed in Ret-eGFPLo:IB4Neg neurons, as were, itch-
associated neurotransmitters such as Nppb (Mishra & Hoon, 2013) and neuromedin B (Nmb) 
(Jensen et al, 2008). Importantly, Il31ra and Osmr, co-receptors for IL-31 were also highly 
expressed in Ret-eGFPLo:IB4Neg neurons suggesting that this population could contribute to 
IL-31 mediated pruritus in atopic dermatitis.  
To further investigate whether itch-associated receptor transcripts were indeed specifically 
expressed in Ret-eGFPLo:IB4Neg neuron, we performed a second microarray screen where we 
assessed differential expression in this population with respect to all DRG neurons. We sorted 
DRG neurons from Avil-Cre::R26tdRFP mice in which the majority of peripheral sensory are 
marked by RFP fluorescence (Figure E3) and subjected them to microarray analysis. Similar 
to differential screening between Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg populations, this 
dataset was also enriched in itch-associated molecules (Figure 5B). Fold change levels were 
lower than for comparisons with Ret-eGFPHi:IB4Neg neurons (Figure 5C), presumably 
reflecting the mixed molecular profile of all DRG neurons, and the fact that some transcripts 
such as Calca (CGRP) mark large populations of Ret-negative neurons.  
To validate the microarray analysis we performed parallel quantitative RT-PCR analysis of 38 
transcripts in Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg populations using a microfluidic 
platform (Fluidigm). We selected genes that represented not only itch associated transcripts 
but also ion channels, signaling molecules and transcription factors with a demonstrated role 
in the peripheral nervous system. In agreement with microarray data, the highest differential 
expression between Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg neurons was for itch related 
genes such as the neuropeptides Nppb, Sst (somatostatin) and Nts (neurotensin), the 
membrane receptors Il31ra, Osmr, Cysltr2, MrgprA3 and Hrh1, and the signaling molecule 
Plcb3. We also observed higher expression in this population for Ntrk1 (TrkA), Calca 
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(CGRP) and Trpv1 transcripts, marking it as a novel population of Ret-positive neurons, as 
well as the ion channels Trpm6, Trpc6, Trpm2 and P2rx3 and the serotonin receptors Htr1f 
and Htr1a (Figures 5D and E4). In the Ret-eGFPHi:IB4Neg population, we detected almost 10-
fold higher expression of Ret and eGFP, validating the flow cytometry analysis. In addition 
Gfra2 and the mechanosensitive ion channel Piezo 2 (Fam38b) (but not Piezo 1 (Fam38a)) 
were upregulated, supporting the assumption that these neurons function as RA 
mechanoreceptors. Intriguingly, we also observed that this population was enriched in 
transcripts involved in chloride transport including the GABA channel subunits α1 and γ2 
(Gabra1, Gabrg2) and the putative chloride channel anoctamin 6 (Ano6) (Figures 5D and E4).  
 
Functional characterization of Ret-eGFPLo:IB4Neg neurons 
We reasoned that further analysis of upregulated transcripts in the Ret-eGFPLo:IB4Neg 
population would allow us to determine the function of these neurons and establish whether 
they do indeed form a novel population of Ret-positive cells. We selected three highly 
enriched transcripts in Ret-eGFPLo:IB4Neg cells, Sst, Il31ra and Htr1f, and applied genetic and 
pharmacological approaches to determine their function. We first assessed the anatomical 
properties of putative Ret-eGFPLo:IB4Neg neurons by crossing an SstCre driver line (Taniguchi 
et al, 2011) with ReteGFP mice to generate heterozygote Sst-Cre::ReteGFP/+ mice. In DRG 
sections from these animals we detected weak eGFP fluorescence in a rare population of 
neurons corresponding to approximately two positive cells per section (Figure 6). We 
explored this expression pattern in more detail by co-staining sections with IB4, NF200 and 
TH. Importantly, SstCre driven Ret-eGFP expression did not overlap with any of these markers 
(Figures 6A-H) suggesting that Sst does indeed mark the Ret-eGFPLo:IB4Neg  population and 
that this population is unique. We further investigated the peripheral projections of Sst/Ret-
eGFP positive sensory neurons by examining skin sections from Sst-Cre::ReteGFP/+ mice. We 
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detected faint eGFP immunofluorescence at the dermal/epidermal border that overlapped with 
expression of the pan-neuronal marker PGP9.5 and formed free nerve endings (Figures 6 I-L). 
Importantly, this staining pattern was absent from sections taken from control mice not 
expressing Sst-Cre. 
To examine the function of Ret-eGFPLo:IB4Neg neurons we performed ratiometric calcium 
imaging on acutely dissociated DRG from Avil-Cre::ReteGFP/+ mice. Using microscopy we 
were not able to unequivocally assign Ret positive neurons as being either Ret high or low; 
we thus assessed the proportion of Ret-eGFP-negative, Ret-eGFP/IB4-positive and Ret-
eGFP/IB4-negative neurons activated by various stimuli. Based upon the microarray analysis 
we assumed that these neurons may form a population of itch receptors and thus focused on 
their responses to pruritogens. We first investigated their activation by histamine and 
observed that histamine application induced calcium flux across a broad range of cells, of 
which Ret-eGFP/IB4-negative neurons formed a large population (9.7% of all neurons 
responded to histamine, 54% of these were Ret-positive/IB4 negative, Figure E5A). Similarly, 
immunostaining of DRG sections with an antibody against HRH1indicated that many of the 
neurons positive for Ret and negative for IB4 co-expressed HRH1 (Figures E5E-H). We next 
examined neuronal activation by a histamine-independent stimulus by applying low 
concentrations of chloroquine to cells. Again we found that the majority of responses to 
chloroquine were clustered in Ret-eGFP/IB4-negative neurons (5.6% of all neurons responded 
to chloroquine, of which 72% were Ret-eGFP/IB4-negative, Figure E5B). Since the ion 
channels TRPV1 and TRPA1 may act as receptor operated channels for histamine-dependent 
and independent itch respectively, we also investigated response properties to agonists of 
these channels. We observed that the TRPV1 agonist capsaicin and the TRPA1 agonist allyl 
isothiocyanate evoked calcium influx across all three populations. However capsaicin 
responses were confined predominantly to IB4-negative neurons while allyl isothiocyanate 
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activated mainly IB4 positive neurons (Figures E5C and D). Thus itch different inducing 
stimuli activate a broad range of DRG neurons but have a preferential distribution towards the 
Ret-eGFP/IB4-negative population.   
In light of the potential clinical importance of IL-31 to atopic dermatitis and pruritus (Sonkoly 
et al, 2006), we next examined the actions of IL-31 on Ret-eGFPLo:IB4Neg cells. We first 
investigated the expression of IL-31RA in DRG neurons. We were unable to obtain selective 
IL-31RA antibodies that worked for immunofluorescence, and thus developed a method for 
identifying IL-31RA positive neurons based upon fluorescent labeling of recombinant IL-31 
ligand. Mono-biotinylated IL-31 was conjugated with streptavidin Alexa Fluor 546 and 
applied directly to acutely dissociated DRG neurons from Avil-Cre::ReteGFP/+ mice. In 
agreement with microarray analysis we observed that a small population of DRG neurons 
bound IL-31 Alexa Fluor 546 conjugates and that this coincided with weakly fluorescent Ret-
eGFP cells that were mainly negative for IB4 labeling (Figures 7A-D). We next assayed the 
response properties of these cells to IL-31 application using calcium imaging. Strikingly, we 
observed that IL-31 robustly activated a subset of sensory neurons and this effect was almost 
exclusively confined to the Ret-eGFP/IB4-negative population (5.6% of all neurons 
responded to IL-31, of which 83.9% were Ret-eGFP/IB4-negative, Figures 7E-H). Thus IL-31 
may exert some of its pruritogenic effects by directly activating Ret-eGFP/IB4-negative 
sensory neurons.  
Finally we wished to examine a receptor/signaling pathway that has not been explored in the 
context of itch. We selected 5HT1F (Htr1f) because this receptor couples to the inhibition of 
adenylate cyclase (Adham et al, 1993) and we reasoned that its stimulation may therefore 
inhibit neuronal activity. We first immunostained DRG sections with an antibody against 
5HT1F and observed immunoreactivity in a rare subpopulation of neuronal soma that were 
positive for Ret-eGFP and mostly negative for IB4 binding (Figures 7I-L). We explored the 
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function of 5HT1F receptors in this population further by applying the 5HT1F agonist 
LY344864 to neurons from Avil-Cre::Ret+/eGFP mice. Unexpectedly, we found that application 
of low concentrations of LY344864 evoked calcium flux in a subpopulation of neurons that 
was qualitatively similar to that evoked by IL-31, histamine and chloroquine (Figures 7M-O). 
Moreover, this activity was concentrated mainly in the Ret-eGFP/IB4-negative population 
(3.5% of all neurons responded to LY344864, of which 70% were Ret-eGFP/IB4 negative, 
Figure 7P) suggesting that in these cells, 5HT1F signaling can directly evoke calcium flux.  
To explore the role of Ret-eGFP/IB4 negative neurons in generating itch at the in vivo level, 
we reasoned that application of agonists that activate this population should evoke scratching 
behavior and activate second order spinal cord neurons when applied in vivo. We therefore 
injected low concentrations of IL-31 and LY344864 subcutaneously (as well as histamine as a 
positive control) and monitored scratching responses and the induction of C-fos expression in 
spinal cord slices. Strikingly we observed that a single subcutaneous injection of either Il-31 
or LY344864 rapidly evoked scratching behavior to the same extent as histamine (Figure 8A). 
Moreover, application of Il-31 or LY344864 also induced sparse C-fos expression in lamina I 
and lamina IIi/III, that overlapped with Ret-eGFP expression but was largely separate from 
IB4 labeling (Figures 8B-D and E6). Collectively our data indicate that a small subpopulation 
of Ret-positive cells may mediate itch sensation, and that remarkably, very few cells may be 
required to elicit a behavioral scratching response.  
 
DISCUSSION 
Here, we show that a previously uncharacterized population of sensory neurons that express 
the receptor tyrosine kinase Ret may function as itch receptors. Using flow cytometry of 
dissociated DRG neurons we isolated this population based upon its weak expression of Ret 
and absence of IB4 binding. We demonstrate that these neurons express markers common to 
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peptidergic nociceptors such as TrkA and CGRP, and importantly, are highly enriched for 
transcripts associated with itch sensation. Anatomical and functional analysis of these cells 
indicates that they form a rare subtype of DRG neuron that project to the dermal/epidermal 
border of the skin and function to detect itch inducing stimuli.   
Three populations of Ret positive sensory neuron have been previously identified and 
characterized. Early Ret neurons develop into RA mechanoreceptors (Bourane et al, 2009; 
Luo et al, 2009) while late Ret neurons become C-fiber low threshold mechanoreceptors and 
non-peptidergic nociceptors (Li et al, 2011; Molliver et al, 1997). Intriguingly, a fourth 
population of Ret positive neurons has also been described that expresses TrkA in adult mice 
but has unknown function ((Golden et al, 2010; Molliver et al, 1997). This population is 
scarce, corresponding to around 10% of all Ret positive cells (Golden et al, 2010; Molliver et 
al, 1997), and presumably this rarity has made further analysis difficult. By taking advantage 
of the sensitivity and analytic power of flow cytometry, we have isolated these cells and 
performed gene expression profiling to determine their function.  
We initially used histochemistry to identify populations of Ret-eGFP positive neuron 
expressing markers of mechanoreceptors (NF200), non-peptidergic nociceptors (IB4) and 
peptidergic nociceptors (CGRP). However, limited by the number of markers that can be 
applied simultaneously to the same section, we turned to flow cytometry to analyze Ret-
expression in more detail. We based our analysis on the observation that Ret-expression levels 
differ considerably across the DRG, and that low Ret levels correlate with GFRα1/3 
expression (Luo et al, 2007), while high Ret expressing neurons express GFRα2 and form RA 
mechanoreceptors (Bourane et al, 2009; Luo et al, 2009). By co-labeling cells with IB4 we 
were able to distinguish multiple subtypes of Ret positive neurons of which a Ret-low, IB4 
negative population was clearly evident. That this population corresponds to the fourth, 
uncharacterized type of Ret neuron is supported by several lines of evidence. Firstly it is IB4 
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negative, indicating that it is not part of the non-peptidergic nociceptor population. Secondly, 
it expresses almost 10 fold less Ret transcript compared to Ret-eGFPHi:IB4Neg neurons. 
Thirdly, Gfra3 is up-regulated 29 fold in these cells while Gfra2 has 21 fold higher expression 
in the Ret-eGFPHi:IB4Neg population. Finally, we detected many differentially expressed 
genes such as TrkA, CGRP and TRPV1, in the Ret-eGFPLo:IB4Neg population which are 
known to be absent from C-LTMRs or RA mechanoreceptors (Li et al, 2011). While we did 
not perform a similar analysis on IB4 positive neurons, flow cytometry data indicates that a 
further three populations can also be differentiated here which may also form distinct 
functional populations.  
Given the powerful regulatory actions of neurotrophic factors in the peripheral nervous 
system, a major emphasis of previous research has been to investigate how deletion of these 
factors impacts upon the survival, differentiation and maintenance of distinct populations. 
Here, we have not considered the effects of Ret ablation on Ret-eGFPLo:IB4Neg negative 
neurons, concentrating instead upon the initial functional characterization of this population. 
Of note, the number of Ret positive/ TrkA positive neurons is not reduced in Ret nociceptor 
specific conditional knockout mice (Golden et al, 2010), suggesting that this population does 
not require Ret for its survival. It is however possible that the termination pattern of these 
neurons in the skin and spinal cord, and the expression of ion channels and signaling 
molecules is regulated by Ret signaling as has been shown for other populations (Bourane et 
al, 2009; Franck et al, 2011; Golden et al, 2010; Honma et al, 2010; Li et al, 2011; Luo et al, 
2009; Luo et al, 2007; Molliver et al, 1997). The identification of markers, and molecular 
tools with which to target Ret-eGFPLo:IB4Neg negative cells described here would now allow 
for further investigation of these phenotypes.  
Amongst the differentially expressed genes present in Ret-eGFPLo:IB4Neg cells we observed a 
strong enrichment of the neuropeptides CGRP, Nppb, neurotensin (Nts) and somatostatin 
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(Sst). Of these, we focused our attention on Sst because of the availability of an Sst-Cre driver 
line (Taniguchi et al, 2011) which we reasoned could be used to target the Ret-eGFPLo:IB4Neg 
population. Indeed, recombination of the Ret locus by Sst-Cre occurred in very few neurons 
of the DRG, resulting in low eGFP fluorescence in IB4, NF200 and CGRP negative cells, 
analogous to the Ret-eGFPLo:IB4Neg population. In agreement, these neurons formed sparse 
terminations in the skin consistent with a potential role for this population in detecting itch. 
Using this genetic strategy we were unable to assay the central projections of Sst-Cre::ReteGFP 
positive sensory neurons because of native expression of Sst in spinal cord interneurons 
(Proudlock et al, 1993). However, previous studies have shown that the Sst receptor Sst2a (as 
well as the Nts receptor Nts2) are present in laminae I-IV of the spinal cord (Sarret et al, 
2005; Todd et al, 1998), suggesting the possibility that Ret-eGFPLo:IB4Neg may synapse with 
these neurons. Future experiments, perhaps using intersectional genetics to limit Sst-Cre 
expression to peripheral sensory neurons would be able to address these questions.  
We observed that many molecules that have previously been implicated in itch sensation 
showed the highest enrichment in Ret-eGFPLo:IB4Neg. These included transcripts for the 
histamine and chloroquine receptors Hrh1 and Mrgpra3, the signaling molecule Plcb3 and the 
putative neurotransmitter Nppb. Moreover enrichment of itch associated transcripts was also 
evident when assessing expression levels relative to all DRG neurons suggesting that although 
rare, this population may play a role in itch sensation. The expression profile of Ret-
eGFPLo:IB4Neg neurons therefore represents a molecular inventory for these neurons, and 
many more molecules with an as yet unexplored role in itch may be contained within this list. 
To validate the gene expression analysis we performed calcium imaging on acutely 
dissociated DRG neurons from Avil-Cre::ReteGFP mice. In agreement with previous studies we 
observed that histamine activated a broad range of dissociated neurons (Imamachi et al, 
2009), while chloroquine was more specific in its activation profile, evoking calcium influx in 
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approximately 5% of cells (Liu et al, 2009). Of note, our expression analysis and functional 
data indicate that both histamine and chloroquine can activate Ret positive/IB4 negative cells, 
supporting the observation chloroquine sensitive neurons form a subset of histamine 
responders ((Liu et al, 2009). It has been reported that these two pruritogens activate separate 
neuronal pathways in vivo, and distinct neurons in in vitro calcium imaging assays (Roberson 
et al, 2013). Our data argue against a complete separation of histamine dependent and 
independent pathways, and suggest that in Ret positive/IB4 negative cells these different 
mechanisms converge. Indeed Robertson et al (2013) observed a small population of 
trigeminal neurons that respond to both histamine and chloroquine and it is conceivable that 
these neurons may be the trigeminal correlate of Ret positive/IB4 negative neurons in the 
DRG.  
Strikingly, we observed that IL-31 directly activated Ret positive/IB4 negative cells, 
suggesting that this could be the first step in transducing an immune cell derived 
inflammatory cascade into a behavioral scratching response. A similar finding has also been 
recently reported for Thymic Stromal Lymphopoietin (TSLP), an epithelial cell derived 
cytokine that plays a critical role in the development of atopic dermatitis (Wilson et al, 2013). 
TSLP receptor transcripts (Il7r and Crlf2) were not expressed in Ret-eGFPLo:IB4Neg cells and 
accordingly, TSLP directly activated a novel subpopulation of sensory neurons that were not 
sensitive to either histamine of chloroquine (Wilson et al, 2013). Investigation of the relative 
roles of these populations of neuron and their interaction with immune and epithelial cells 
may have important clinical consequences for understanding the progression of allergic 
diseases.  
We were intrigued by the high expression levels of the serotonin receptors Htr1f and Htr1a in 
Ret-eGFPLo:IB4Neg neurons. Serotonin has a well-established pruritogenic action when 
applied subcutaneously and this effect is mediated by 5-HT2 receptors (Nojima & Carstens, 
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2003; Yamaguchi et al, 1999). Transcripts for 5-HT2 receptors were not upregulated in Ret-
eGFPLo:IB4Neg cells and we did not investigate further whether serotonin directly activates 
these cells. Instead we focused on the 5HT1F receptor because it is coupled to Gi signaling and 
should therefore inhibit neuronal activation. Unexpectedly we observed an apparent activation 
of Ret-eGFP/IB4-negative sensory neurons by the 5HT1F agonist LY344864, and robust 
scratching behavior when LY344864 was injected subcutaneously. A potential basis for this 
effect may come from the observation that many Gi coupled receptors are able to interact with 
G14 subunits promoting the stimulation of phospholipase C (Ho et al, 2001). Indeed the 
transcript for G14 (Gna14) was amongst the most differentially expressed genes in Ret-
eGFPLo:IB4Neg neurons (Figures 5A-C), and thus its presence could expand the signaling 
repertoire of these cells allowing for Gi coupled receptors such as 5HT1F to generate neuronal 
activity. Of note, 5HT1F receptor agonists have also been proposed as clinical targets for the 
treatment of migraine (Goadsby, 2005). Our data indicates that these compounds could have 
unwanted side-effects via activation of Ret-eGFPLo:IB4Neg neurons and generation of itch.  
An important question that arises from our expression data is whether the presence of multiple 
itch associated transcripts in Ret-eGFPLo:IB4Neg neurons is sufficient to define them as itch 
receptors. In support of this notion, we observed that agonists which selectively activate these 
neurons at the cellular level (IL-31, LY344864) evoked scratching behavior when injected in 
vivo. Similarly, the chloroquine receptor Mrgpra3 was enriched in Ret-eGFPLo:IB4Neg cells, 
and chloroquine application induced calcium flux predominantly in the Ret-eGFP/IB4-
negative population. Since ablation of Mrgpra3 positive neurons impacts upon scratching 
behavior but not pain (Han et al, 2013), this would suggest that Ret-eGFPLo:IB4Neg neurons 
are indeed itch receptors and that multiple itch inducing pathways coexist within these 
neurons. Thus therapeutic strategies for treating itch should target common signaling 
molecules or disrupt neuronal function, rather than inhibit specific receptors. The 
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transcriptional profiling approach described here is a first step towards identifying these 
molecules. 
 
MATERIALS AND METHODS 
Transgenic Mouse lines 
To study Ret expression in adult primary sensory neurons we crossed RETeGFP/+ mice (Jain et 
al, 2006) with the DRG neuron specific Cre line Avilcre/+ (Zurborg et al, 2011) to obtain Avil-
Cre::RETeGFP/+ mice. We also used the Avilcre/+ line to mark sensory neurons within the DRG 
by crossing it with a Rosa26-tdRFP strain (Luche et al, 2007) to generate Avil-Cre::R26tdRFP 
mice. To specifically mark Ret-eGFPLo:IB4Neg neurons we bred Sst-Cre (Taniguchi et al, 
2011) and  RETeGFP/+ mice, thus obtaining  Sst-Cre::Ret eGFP/+ animals. Heterozygous mice 
were all viable and exhibited no overt behavioural phenotype. 
Mice were bred and maintained at the EMBL Mouse Biology Unit, Monterotondo, in 
accordance with Italian legislation (Art. 9, 27. Jan 1992, no 116) under licence from the 
Italian Ministry of Health. 
Immunofluorescence 
DRG and spinal cord from adult mice (6 weeks or older) were postfixed in 4%PFA for 30 
minutes (DRG) or two hours (SC), embedded in 12% bovine gelatin and sectioned using a 
vibratome at 50-100 µm. Sections were incubated for 30 minutes in 50% ethanol and then 
overnight in 0,3% TritonX , and 5% goat or donkey serum in PBS at 4C containing one or 
more antibodies diluted as shown below. Secondary antibodies and streptavidin-647 were 
diluted (1:1000 and 1:600 respectively) in 0,3%TritonX , 5% goat or donkey serum in PBS 
and left for 1-2h at 4C. Slides were mounted with Prolong gold antifade (Invitrogen, P36930). 
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For immunofluorescence analysis of the skin, the hair was removed and skin collected and 
post-fixed in 4% PFA for 8-12h, incubated in 30% sucrose overnight and frozen in OCT. 35 
µm sections were cut with a cryostat. Antibody staining was performed as described above. 
We used the following primary antibody dilutions: Rabbit anti-NF200 (Sigma Aldrich, 
N0142) 1:500, goat anti-CGRP (Santa Cruz, SC8856), rabbit anti-PKCγ (Santa Cruz, SC-211) 
1:100, rabbit anti-Htr1f (Novus, NBP1-19625) 1:100, Rabbit anti-H1 histamine receptor 
(Alamone labs AHR-001) 1:200, rabbit anti-PGP9.5 (Dako, Z5116) 1:200, Isolectin GS-B4-
biotin XX conjugate (Invitrogen I21414) 1:100, Rabbit anti-c-Fos (EMD Millipore, PC38), 
1:20000, anti-RFP (Rockland, 600-401-379), 1:200, Rabbit anti-TH, (Millipore, AB152), 
dilution 1:1000. All images were visualized with a Leica SP5 Confocal microscope and 
analyzed with ImageJ. 
Flow Cytometry and Microarray Analysis 
To quantitavely analyze the distribution of Ret+ sensory neurons in DRG we used flow cytometry on 
Avil-Cre::RETeGFP/+ mice: DRG were collected from 10 adult Avil-Cre::RETeGFP/+ mice (6 weeks or 
older) and pooled. Cells were dissociated with 1mg/ml collagenase IV and 0.05% Trypsin (Gibco, 
25300-054) for 25 min each at 37C and subsequently kept on ice in 1%FBS in PBS. Cells were 
labeled in suspension with 1:50 anti-mouse CD16/32 (eBioscience 14-0161-85) for 5 minutes and 
Isolectin GS-B4-biotin XX conjugate (1:100) for 10 minutes. After washing, cells were incubated 
immediately with a cocktail containing Streptavidin-Alexa 647 and anti-CD45-PeCy7 for 5 min, 
washed, and resuspended in 1%FBS in PBS.  
To isolate the whole sensory neuron population, we applied flow cytometric analysis and subsequent 
sorting on Avil-Cre::RFPtg/+ mice: DRG were collected from 3 adult Avil-Cre::RETeGFP/+ mice (6 
weeks or older) and pooled. Cell dissociation was performed as described above. Cells were then 
labeled in suspension with 1:50 anti-mouse CD16/32 (eBioscience 14-0161-85) for 5 minutes and 
after washing cells were incubated in anti-CD45-PeCy7 (1:200) for 5 min, washed, and resuspended in 
1%FBS in PBS.   
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Flow cytometric online and offline analyses were performed in a FACS Aria III SORP (BD 
Bioscience) using FACS Diva software (BD Bioscience) and FlowJo (Tree Star, Inc.), respectively. 
For gene expression analysis, DRG cells were sorted (see Supp. Fig. 1a) using an 85 µm nozzle (40 
PSI) directly into RLT buffer (RNeasy kit, Qiagen) and RNA was purified according to manufacturer 
instructions. Two rounds of RNA amplification, labeling and hybridization to Affymetrix® MOE430 
2.0 GeneChip® expression arrays were performed by the EMBL Gene Core Facility. Microarray data 
was analyzed as detailed in Expanded View Information.  
Fluidigm 
To validate the microarray data we used the microfluidic platform Fluidigm to perform 
quantitative RT-PCR. DRG from Avil-Cre::RETeGFP/+ mice were collected and processed as 
described above. Cells were sorted directly into 5µl of CellsDirect (Invitrogen, PN 11753-100 
and 11753-500) 2x Buffer, and combined with 0.2µl of RT / Taq mix, 1µl of Assay pool 
(formed by 38 individual assay pairs that were previously pooled and diluted to a final 
concentration of 500nM) and 2.8µl of water. The samples went through target specific RT and 
pre-amplification (16 cycles) following manufacturer instructions. Pre-amplified cDNA was 
then diluted 1:10 and combined together with 2.5µl 2x SsoFast Evagreen Supermix (Bio-Rad, 
PN 172-5211) and 0.25µl 20x Sample Loading Reagent (Fluidigm, PN 100-0388) and loaded 
onto the sample inlets of a 48.48 Fluidigm Dynamic Array. All 38 individual assays pairs 
(100uM) were diluted by combining 0.25µl of each assay with 2.25µl of TE Buffer 
(TEKnova, PN T0224) and 2.5µl of Assay Loading Reagent (Fluidigm, PN 85000736). The 
48.48 chip was then loaded on the IFC Controller MX and 30 cycles of qPCR was performed 
on the Fluidigm BioMark HD system. Data was analyzed using Fluidigm Real-Time Analysis 
Software.  
Mono-biotinylated IL-31 labeling  
Monobiotinylated IL-31 was produced and biotinylated as described in Expanded View 
Experimental Procedures. Equimolar biotinylated IL-31 was conjugated with streptavidin 
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Alexa Fluor 546 for 30 minutes at 4C. Dissociated DRG neurons from Avil-Cre::ReteGFP mice 
were plated on glass coverslips and washed for one hour in CIB with 1% BSA (140mM 
NaCL, 4mM KCl, 2mM CaCl2, 1mM MgCl2, 4,55 mM NaOH, 5 mM Glucose, 10 mM 
HEPES, pH 7,4). IL-31 Alexa Fluor 546 conjugate was then applied at 1nM concentration in 
CIB plus 1% BSA for 30 minutes at 4C along with IB4-647 at 1:800 dilution. Following 
labeling, cells were washed 3 times with CIB plus 1% BSA and then fixed for 5 minutes in 
4% PFA before mounting. As a negative control, 1nM streptavidin Alexa Fluor 546 was 
applied to cells using an identical procedure and no membrane staining was evident  
Calcium Imaging 
DRG from adult Avil-Cre::RETeGFP/+ mice were collected and incubated in 1mg/ml 
collagenase IV (Sigma Aldrich, C5138) and 0,05% Trypsin (Gibco, 25300-054) for 25 
minutes each at 37C. They were then suspended in DRG medium (DMEM -Gibco, 41966-
029- with 10% heat inactivated Fetal Bovine Serum –PAA, A15101-, 0,8% Glucose and 
100U of Penicillin/Streptomycin –Gibco, 15140-122-). Cells were plated in a droplet of 
medium on glass coverslips treated with Poly-L-lysine and left to attach for 3 hours at 37C. 
IB4 staining (Isolectin GS-B4-biotin XX conjugate, Invitrogen, I21414) was performed at 
1:100 dilution ( in 1%FBS/PBS) followed by 5 minute incubation in 1:600 Streptavidin 546 
(Invitrogen, S11225). Cells were then incubated in 3 µM Fura2-AM (Invitrogen, F1221) in 
CIB (140mM NaCL, 4mM KCl, 2mM CaCl2, 1mM MgCl2, 4,55 mM NaOH, 5 mM Glucose, 
10 mM HEPES, pH 7,4) and calcium imaging was performed as described (Caspani et al, 
2009). Concentrations of compounds used were: Histamine 1 µM (Sigma, H7250), 30 nM 
LY344864 30 nM (Abcam, ab120592), IL31 (Peprotech, 210-31) 2 nM, Choloroquine 
(Sigma, C 6628) 500 µM, allyl isothiocyanate (Sigma) 100 µM 
Behavior  
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6-8 week old C57BL/6J or Avil-cre::RETeGFP/+ mice were acclimated for one day. The following day 
they were injected subcutaneously with 100 µl solution in the nape of the neck with one of the 
following reagents: 10mM Histamine (Sigma, H7250) in saline, 1mM LY344864 (Abcam, ab120592) 
in saline, IL31 (Peprotech, 210-31) in 0,1% BSA/PBS. Control injections were performed with 
appropriate vehicle. Animals were observed for 30 minutes and bouts of scratching counted. In some 
cases, 1 hour after injections, the cervical part of the spinal cord was collected for c-Fos staining 
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Figure 1. Ret-eGFP is Expressed in Multiple Sensory Neuron Subsets 
(A−L) Ret-positive neurons largely overlap with markers for myelinated neurons (NF200), 
non-peptidergic nociceptors (IB4) and C-fiber low-threshold mechanoreceptors (TH). 
However some Ret positive neurons are negative for these markers (indicated by the arrows in 
D,H and N) suggesting the existence of a further subset of Ret+  neurons. (O−R) A small 
proportion of Ret positive cells coincides with CGRP-expressing neurons (arrowheads in P), 
reflecting an uncharacterized subpopulation of sensory neurons. Scale bars, 50 µm. 
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Figure 2. Ret-eGFP Fluorescence Is Widely Distributed in the Skin 
 (A−C) Ret-eGFP free nerve endings are broadly distributed in the dermis and epidermis of 
the skin. Double immunofluorescence of Ret-eGFP (A) and the pan-neuronal marker PGP9.5 
(B) in adult Avil-Cre::Ret+/eGFP mouse hairy skin. Dashed line indicates the dermis/epidermis 
junction. Scale bar, 50 µm. (D−F) Ret-eGFP fibers also terminate as lanceolate endings 
encircling hairs.  Double immunostaining of Ret-eGFP (D) and the pan-neuronal marker 
PGP9.5 (E) in adult Avil-Cre::Ret+/eGFP mouse hairy skin. Scale bar, 25 µm,  
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Figure 3. Central Terminals of Ret-eGFP Expressing Primary Sensory Neurons Are 
Broadly Distributed Within The Dorsal Horn of the Spinal Cord 
Spinal cord cross-sections from adult Avil-Cre::Ret+/eGFP mice labeled with the indicated 
markers. (A−D) Ret-eGFP fluorescence is strongly expressed in lamina IIo  and partially 
overlaps with Lamina I. Triple immunofluorescene of Ret-eGFP (A) with IB4 (B) and CGRP 
(C). (E−H) Ret-eGFP expression in lamina IIi/III. Triple immunofluorescence of Ret-eGFP 
(E) with IB4 (F) and PKCγ (G), a marker for lamina IIi/III interneurons. (I−L) Ret-eGFP is  
expressed diffusely through laminae III to V. Triple immunostaining of Ret-eGFP (I) with 
NF200 (J) and PKCγ (K). Scale bar, 100 µm. 
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Figure 4. Multiple Ret-positive Subpopulations as Determined by Flow Cytometric 
Analysis of Dissociated Sensory Neurons from Avil-Cre::Ret+/eGFP Mice  
(A) Flow cytometric analysis of dissociated sensory neurons plotted according to their level of 
endogenous Ret-eGFP expression and IB4 binding. There are 5 well-defined subsets, 2 out of 
which do not bind to IB4 but display a differential level of eGFP intensity (termed Ret-
eGFPLo:IB4Neg, A, and  Ret-eGFPHi:IB4Neg ,B, respectively). The other 3 subsets bind IB4 and 
display a range of eGFP intensities, termed Ret-eGFPLo:IB4Lo, C, Ret-eGFPHi:IB4Lo, D, and 
Ret-eGFPHi:IB4Hi, E. (B) No correlation between the median cell size of different Ret+ subsets 
and eGFP intensity or IB4 binding. The graph shows the forward scatter values plotted against 
the normalized number of cells, displayed as the percent of Max. (C−D) Variations in 
endogenous eGFP intensity are clearly visible with fluorescent microscopy. (C) Cultured 
neurons and (D) DRG section from Avil-Cre::Ret+/eGFP  mice displaying native eGFP 
fluorescence and stained with IB4. Different levels of eGFP intensity (high -indicated by 
arrows and low -indicated by arrowheads) are detected across IB4+ and IB4- cells. Scale bar, 
50 µm.  
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Figure 5. Transcriptional profiling of Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg 
Sensory Neurons. 
(A) Ret-eGFPHi:IB4Neg and Ret-eGFPLo:IB4Neg  neurons display distinct expression profiles. A 
volcano plot of fold change expression in Ret-eGFPLo:IB4Neg versus Ret-eGFPHi:IB4Neg 
against probability. Ret has higher expression in the Ret-eGFPHi:IB4Neg subset, which also 
shows an up regulation of the Ret co-receptor Gfra2 and Fam38b, encoding for the 
mechanosensitive ion channel Piezo2. The Ret-eGFPLo:IB4Neg subset, displays an array of 
molecules previously associated with itch (marked in red). (B) Itch-associated transcripts are 
enriched in the Ret-eGFPLo:IB4Neg population compared to all DRG neurons. Volcano plot of 
fold change expression in Ret-eGFPLo:IB4Neg neurons versus sorted neurons from Avil-
Cre::R26tdRFP mice against probability. Molecules linked to itch perception are significantly 
upregulated in the Ret-eGFPLo:IB4Neg subset. (C) Gene expression within the Ret-
eGFPLo:IB4Neg population is confirmed by triple comparison between Ret-eGFPLo:IB4Neg, 
Ret-eGFPHi:IB4Neg and Avil-Cre::R26tdRFPdatasets. (D) Validation of differential microarray 
screening by quantitative RT-PCR. Transcripts encoding ion channels, receptors, 
neuropeptides, signaling molecules and transcription factors were selected for quantitative 
RT-PCR. Differential expression between Ret-eGFPLo:IB4Neg and Ret-eGFPHi:IB4Neg 
populations correlates with microarray analysis.  
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Figure 6. SstCre Driven Ret-eGFP Expression in DRG and Hairy Skin. 
(A−H) SstCre mediated recombination of the Ret locus drives eGFP expression in sensory 
neurons that do not bind to IB4 or co-express NF200 or TH. Triple immunostaining of DRG 
from Sst-Cre::ReteGFP/+ with RetGFP (A), IB4 (B) and NF200 (C), and RetGFP (E), IB4 (F) 
and TH (G). (I−L) Peripheral projections of sensory neurons from Sst-Cre::ReteGFP/+ mice 
terminate in the hairy skin as free nerve endings (arrows). Triple immunostaining of Ret-
eGFP (I), DAPI (J) and PGP9.5 (K). Dashed line indicates the dermis/epidermis junction. 
Scale bars, 50 µm. 
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Figure 7. Il-31 and the 5HT1F Agonist LY344864 Activate Ret-eGFP/IB4 Negative 
Neurons 
(A−H) IL-31 binds to and activates Ret-eGFP/IB4 negative neurons. (A−D) Biotinylated IL-
31 binds to the plasma membrane of a small subset of weakly fluorescent Ret-eGFP+ cells 
which are IB4 negative (arrow). Live imaging of cells isolated from Avil-Cre::Ret+/eGFP  mice 
and co-stained with IB4 (B) and 1nM biotinylated IL31 conjugated to streptavidin Alexa 
Fluor 546. (C). (E−H) IL-31 evokes calcium flux in Ret-eGFP/IB4 negative neurons. (E) 
Dissociated sensory neurons isolated from adult Avil-Cre::Ret+/eGFP  mice and stained with 
IB4. (F) Fura-2 fluorescent intensity changes for the same cells upon application of 2nM IL-
31, and (G) example of IL-31 response. (H) IL-31 responses are mainly confined to Ret-
eGFP/IB4 negative neurons (numbers in parenthesis indicate percentages, n=3 mice). (I−P) 
The 5HT1F receptor is expressed in Ret-eGFP/IB4 negative neurons. (I−L) Triple 
immunostaining of DRG sections of Avil-Cre::Ret+/eGFP showing Ret-eGFP (I), IB4 (J) and 
5HT1F (K). Arrowheads (L) indicate 5HT1F cells that are IB4 positive and weakly express 
Ret-eGFP. (M) Dissociated sensory neurons isolated from adult Avil-Cre::Ret+/eGFP  mice and 
stained with IB4. (N) Fura-2 fluorescent intensity changes for the same cells upon application 
of 30nM LY344864, and (O) an example of their response. (P) LY344864 activates mainly 
Ret-eGFP/IB4  
negative neurons (numbers in parenthesis indicate percentages, n=3 mice). Scale bars, 50 µm 
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Figure 8. IL-31 and LY344864 Elicit Scratching Behavior in Mice and C-fos Activation 
in the Spinal Cord. 
(A) A single subcutaneous injection of histamine (positive control), IL-31 or LY344864 
evokes significantly more scratching bouts than injection of vehicle alone. The scratching 
behavior was observed for 30 minutes after the injection. (B−C) Application of IL-31 or 
LY344864 induces sparse activation of C-fos expression which overlaps with the Ret-eGFP 
positive neurons in laminae I and IIi/III. IL-31 (B) and LY344864 (C) induced c-fos activation 
in Avil-Cre::Ret+/eGFP  mouse cervical spinal cord cross-sections. Scale bars, 50 µm.  
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Figure E1. Avil-Cre::Ret+/eGFP DRG Cell Sorting Strategy  
Hierarchical gating strategy for the isolation of live Ret+ sensory neurons. DRG cells were 
isolated from Avil-Cre::Ret+/eGFP mice, quantified and selected according to their size and 
complexity. Dead cells and immune cells were excluded using the living dye Sytox Blue, and an 
antibody against cd45. Live sensory neurons were defined by their levels of eGFP fluorescence 
and IB4 binding. Percentages from parent populations are indicated in each graph.  
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Figure E2. Microarray quality control 
(A) R ratios between the expression values for 3’ and 5’ ends of GAPDH and â-actin mRNA 
transcripts. No suspect 3’ to 5’ signal intensity ratio was found. Probesets marked as Present 
range around 41.5% – 47.62%, while the background levels are up to 38.88.  Each row shows 
the %present, average background, scale factors and GAPDH / -actin ratios for an individual 
chip. GAPDH 3 ‘: 5’ values are plotted as circles. GAPDH values that are considered potential 
outlier (ratio > 1.25) are coloured red, otherwise they are blue. â-actin, 3’: 5’ ratios are plotted as 
triangles. Because this is a longer gene, the recommendation is for the 3’: 5’ ratios to be below 
3; values below 3 are colored blue, those above, red. Blue stripe in the image represents the 
range where scale factors are within 3-fold of the mean for all chips. Scale factors are plotted as 
a line from the center line of the image. A line to the left corresponds to a down-scaling, to the 
right, to an up-scaling. If any scale factors fall outside this 3-fold region, they are colored red, 
otherwise they are blue. (B) The Normalized Unscaled Standard Errors (NUSE) were plotted to 
account for differences in variability between genes. The standard error estimates obtained for 
each probe set on each array were taken and standardized across arrays so that the median 
standard error for each type of probe set was 1 across all arrays. All boxplots on the graph 
should be similar and the median should be 1 across all arrays. All arrays were observed to be 
of similar quality. (C) PCA plot of RMA8 normalized, GC content adjusted array data. Both 
panels show a different angle of the PCA plot. Low intragroup variability was observed, while 
group differences are discernible. The first principal component (X- axis) explains 30.6% of data 
variation, while the second principal component (Y-axis) explains 19.6% of data variation. The 
third principal component (Z-axis) explains 16.2% of data variation. Group color codes Blue: 
GH_GFP_low, Red: GH_GFP_high. Illustrations made with Partek® Genomics suite software 
ver6.3. 
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Figure E3. Avil-Cre::R26tdRFP DRG Cell Sorting Strategy  
(A) Hierarchical gating strategy for the isolation of RFP+CD45- living cells from single cell 
suspensions of DRG isolated from Avil-Cre::R26tdRFP mice. Percentages from parent populations 
are indicated in each graph. (B) Last gate corresponding to control animals not expressing Cre 
recombinase. 
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Figure E4. Validation of the Microarray Screens by Quantitative RT-PCR 
The expression of 38 genes was validated using the microfluidic platform Fluidigm. Their 
relative expression, normalized to GAPDH, is shown here (± SEM). Expression in the Ret-
eGFPHi:IB4Neg subset  is indicated in blue, and expression in the Ret-eGFPLo:IB4Neg  subset  is in 
red. 
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Figure E5. Activation Profile of Ret-eGFP/IB4 Negative Neurons 
Ratiometric calcium imaging was performed on sensory neurons dissociated from Avil-
Cre::Ret+/eGFP mice, to assess the proportion of (A) Histamine, (B) Chloroquine, (C) Allyl 
isothiocyanate and (D) Capsaicin responsive cells that were Ret-eGFP-negative, Ret-eGFP/IB4-
positive and Ret-eGFP/IB4-negative. The expression of the Histamine receptor 1 in Ret-
eGFP/IB4 negative subpopulation is shown by immunostaining. (E- H) Triple immunostaining of 
RetGFP (E), IB4 (F) and HRH1 (G) on DRG sections from Avil-Cre::Ret+/eGFP mice. 
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Figure E6. Pruritogens Induce c-Fos Expression in Cervical Spinal Cord After 
Subcutaneous Injection  
C-fos activation in Avil-Cre::Ret+/eGFP mouse spinal cord cross-sections after injection of 1ìmol 
Histamine (A- D), 55pmol IL-31 (E- H), 100nmol LY344864 (I- L). IB4 binding is also shown. 
Scalebar 50 ìm. 
